[{"path":"/LICENSE.html","id":null,"dir":"","previous_headings":"","what":"MIT License","title":"MIT License","text":"Copyright (c) 2023 ddir authors Permission hereby granted, free charge, person obtaining copy software associated documentation files (“Software”), deal Software without restriction, including without limitation rights use, copy, modify, merge, publish, distribute, sublicense, /sell copies Software, permit persons Software furnished , subject following conditions: copyright notice permission notice shall included copies substantial portions Software. SOFTWARE PROVIDED “”, WITHOUT WARRANTY KIND, EXPRESS IMPLIED, INCLUDING LIMITED WARRANTIES MERCHANTABILITY, FITNESS PARTICULAR PURPOSE NONINFRINGEMENT. EVENT SHALL AUTHORS COPYRIGHT HOLDERS LIABLE CLAIM, DAMAGES LIABILITY, WHETHER ACTION CONTRACT, TORT OTHERWISE, ARISING , CONNECTION SOFTWARE USE DEALINGS SOFTWARE.","code":""},{"path":"/articles/ddi-assessment.html","id":"regulatory-background","dir":"Articles","previous_headings":"","what":"Regulatory background","title":"DDI assessment","text":"May-2024, ICH published new harmonized guidance assessment enzyme- transporter-mediated drug interactions adopted ICH-abiding regulatory agencies, including FDA, EMA PMDA. Currently (Nov-2024), following guidance documents provided individual regulatory authorities: M12 Drug Interaction Studies (FDA, Aug-2024) M12 Questions Answers document (Aug-2024) ICH M12 Drug Interaction Studies (EMA, May-2024)","code":""},{"path":"/articles/ddi-assessment.html","id":"drug-properties","dir":"Articles","previous_headings":"","what":"Drug properties","title":"DDI assessment","text":"general concept, risk enzyme transporter interactions evaluated given drug exposure level corresponds maximal unbound clinical exposure relevant pharmacokinetic compartment. interactions hepatic enzymes, unbound maximal plasma concentration steady state (\\(I_{max,ss,u}\\)) considered, intestinal enzymes victim orally administered drugs, maximal clinical dose, dissolved volume 250 mg (\\(I_{gut}\\)). interactions basolateral hepatic transporters (OATP1B1, OATP1B3), unbound hepatic inlet concentration (\\(I_{max,inlet,u}\\)) considered composed \\(I_{max,ss,u}\\) portal venous term reflecting intestinally absorbed drug escaping gut metabolism. concentrations can automatically derived following set drug-specific parameters: specification key compound parameters therefore first step formal analysis. scope package, key parameters aggregated ‘perpetrator’ object. package contains sample perpetrator object ficitional drug ‘examplinib’: ddir package provides multiple options create perpetrator objects. simplest case, function make_perpetrator() can used: options presented dedicated vignette (see vignette(\"load-data\")). facilitate generation R notebook-based reports, property_table() can used print markdown-formatted table key compound parameters: Compound parameters examplinib","code":"examplinib_parent #> ----- DDI perpetrator object ----- #> name         examplinib                    #> oral         TRUE                          #> mw           492.6                         #> dose         450          clinical dose    #> imaxss       3530         study 001        #> fu           0.023        study 002        #> fumic        1            default          #> rb           1            study 003        #> fa           0.81         study 003        #> fg           1            default          #> ka           0.00267      unknown          #> solubility   Inf          default perp <- make_perpetrator(   name = \"test\",   dose = 100,   imaxss = 1000,   mw = 500,   oral = TRUE,   fu = 1,   fumic = 1,   rb = 1,   fa = 1,   fg = 1,   ka = 0.1,   solubility = Inf ) property_table(examplinib_parent)"},{"path":"/articles/ddi-assessment.html","id":"perpetrator-concentrations","dir":"Articles","previous_headings":"","what":"Perpetrator concentrations","title":"DDI assessment","text":"relevant perpetrator concentrations (\\(\\mu M\\)) perpetrator compound can determined using key_concentrations() - please see documentation function details calculations. function returns named numeric vector naked concentrations, markdown-formatted tabular output can directly embedded R notebook documents can generated using `conc_table()’: Key perpetrator concentrations examplinib","code":"key_concentrations(examplinib_parent) #>         igut      imaxssu   imaxinletu   imaxintest  #> 3654.0803898    0.1648193    0.1929384    6.5855664  conc_table(examplinib_parent)"},{"path":[]},{"path":"/articles/ddi-assessment.html","id":"cyp-enzymes","dir":"Articles","previous_headings":"Direct enzyme inhibition","what":"CYP enzymes","title":"DDI assessment","text":"Risk direct CYP inhibition examplinib, basic model","code":"basic_cyp_inhibition_risk(examplinib_parent, examplinib_cyp_inhibition_data) #>       cyp    ki   kiu      r risk_hep    r_gut risk_intest #> 1  CYP1A2    NA    NA     NA       NA       NA          NA #> 2  CYP2B6    NA    NA     NA       NA       NA          NA #> 3  CYP2C8 11.00 11.00 0.0150    FALSE       NA          NA #> 4  CYP2C9  0.60  0.60 0.2747     TRUE       NA          NA #> 5 CYP2C19  0.25  0.25 0.6593     TRUE       NA          NA #> 6  CYP2D6    NA    NA     NA       NA       NA          NA #> 7  CYP3A4 12.50 12.50 0.0132    FALSE 292.3264        TRUE  basic_cyp_inhibition_risk_table(examplinib_parent, examplinib_cyp_inhibition_data)"},{"path":"/articles/ddi-assessment.html","id":"ugt-enzymes","dir":"Articles","previous_headings":"Direct enzyme inhibition","what":"UGT enzymes","title":"DDI assessment","text":"Risk UGT inhibition examplinib, basic model","code":"basic_ugt_inhibition_risk(examplinib_parent, examplinib_ugt_inhibition_data) #>       ugt  kiu          r risk #> 1  UGT1A1 7.50 0.02197591 TRUE #> 2  UGT1A3 7.50 0.02197591 TRUE #> 3  UGT1A4 7.50 0.02197591 TRUE #> 4  UGT1A6 7.50 0.02197591 TRUE #> 5  UGT1A9 1.90 0.08674701 TRUE #> 6  UGT2B7 7.50 0.02197591 TRUE #> 7 UGT2B15 7.50 0.02197591 TRUE #> 8 UGT2B17 3.05 0.05403912 TRUE  basic_ugt_inhibition_risk_table(examplinib_parent, examplinib_ugt_inhibition_data)"},{"path":"/articles/ddi-assessment.html","id":"time-dependent-enzyme-inhibition","dir":"Articles","previous_headings":"","what":"Time-dependent enzyme inhibition","title":"DDI assessment","text":"Risk CYP TDI examplinib, basic model","code":"basic_cyp_tdi_risk(examplinib_parent, examplinib_cyp_tdi_data) #>      cyp   ki    fu kinact   kdeg    source        r risk #> 1 CYP3A4 0.17 0.023   0.04 0.0193 study 001 3.062752 TRUE  basic_cyp_tdi_risk_table(examplinib_parent, examplinib_cyp_tdi_data)"},{"path":[]},{"path":"/articles/ddi-assessment.html","id":"fold-change-method","dir":"Articles","previous_headings":"CYP induction","what":"Fold-change method","title":"DDI assessment","text":"Risk hepatic CYP induction examplinib, basic mRNA fold-change method","code":"static_cyp_induction_risk(examplinib_parent, examplinib_cyp_induction_data) #>       cyp emax maxc    source maxc_imaxssu  risk     note #> 1  CYP1A2 1.00    5 study 007         30.3 FALSE Low maxc #> 2  CYP2B6 1.00    5 study 007         30.3 FALSE Low maxc #> 3  CYP2C8   NA   NA                     NA    NA          #> 4  CYP2C9   NA   NA                     NA    NA          #> 5 CYP2C19   NA   NA                     NA    NA          #> 6  CYP2D6   NA   NA                     NA    NA          #> 7  CYP3A4 7.35    3 study 007         18.2  TRUE Low maxc  static_cyp_induction_risk_table(examplinib_parent, examplinib_cyp_induction_data)"},{"path":"/articles/ddi-assessment.html","id":"basic-kinetic-model","dir":"Articles","previous_headings":"CYP induction","what":"Basic kinetic model","title":"DDI assessment","text":"Risk CYP induction examplinib, basic kinetic model","code":"kinetic_cyp_induction_risk(examplinib_parent, examplinib_cyp_induction_data) #>       cyp emax ec50 maxc    source         r risk #> 1  CYP1A2 1.00   NA    5 study 007        NA   NA #> 2  CYP2B6 1.00   NA    5 study 007        NA   NA #> 3  CYP2C8   NA   NA   NA                  NA   NA #> 4  CYP2C9   NA   NA   NA                  NA   NA #> 5 CYP2C19   NA   NA   NA                  NA   NA #> 6  CYP2D6   NA   NA   NA                  NA   NA #> 7  CYP3A4 7.35 1.64    3 study 007 0.2134856 TRUE  kinetic_cyp_induction_risk_table(examplinib_parent, examplinib_cyp_induction_data)"},{"path":"/articles/ddi-assessment.html","id":"mechanistic-static-assessment-of-cyp-related-ddi","dir":"Articles","previous_headings":"","what":"Mechanistic-static assessment of CYP-related DDI","title":"DDI assessment","text":"Mechanistic static modeling CYP inhibition risk examplinib","code":"mech_stat_cyp_risk(examplinib_parent, examplinib_cyp_inhibition_data,                    examplinib_cyp_induction_data) #>       cyp   substrate   kiu fgut   fm fmcyp         Ag        Ah Bg Bh       Cg #> 1  CYP1A2  tizanidine    NA 1.00 0.95  0.98 1.00000000 1.0000000  1  1 1.000000 #> 2  CYP2B6        <NA>    NA   NA   NA    NA 1.00000000 1.0000000  1  1 1.000000 #> 3  CYP2C8 repaglinide 11.00 1.00 1.00  0.61 0.62551298 0.9827625  1  1 1.000000 #> 4  CYP2C9  S-warfarin  0.60 1.00 1.00  0.91 0.08350072 0.7566792  1  1 1.000000 #> 5 CYP2C19  omeprazole  0.25 1.00 1.00  0.87 0.03657341 0.5644126  1  1 1.000000 #> 6  CYP2D6 desipramine    NA 1.00 1.00  0.85 1.00000000 1.0000000  1  1 1.000000 #> 7  CYP3A4   midazolam 12.50 0.57 0.96  1.00 0.65494520 0.9847995  1  1 6.884569 #>         Ch      aucr  risk #> 1 1.000000 1.0000000 FALSE #> 2 1.000000        NA    NA #> 3 1.000000 1.0106266 FALSE #> 4 1.000000 1.2843927  TRUE #> 5 1.000000 1.6102050  TRUE #> 6 1.000000 1.0000000 FALSE #> 7 1.773674 0.2321612  TRUE  mech_stat_cyp_risk_table(examplinib_parent, examplinib_cyp_inhibition_data,                          examplinib_cyp_induction_data)"},{"path":"/articles/ddi-assessment.html","id":"transporter-inhibition","dir":"Articles","previous_headings":"","what":"Transporter inhibition","title":"DDI assessment","text":"Risk drug transporter inhibition examplinib","code":"transporter_inhibition_risk(examplinib_parent, examplinib_transporter_inhibition_data) #>    transporter   ic50    source          i            r threshold  risk #> 1      Pgp_int   0.41 study 005       igut 8.912391e+03     10.00  TRUE #> 2      Pgp_sys   0.41 study 005    imaxssu 4.019984e-01      0.02  TRUE #> 3     BCRP_int   1.90 study 005       igut 1.923200e+03     10.00  TRUE #> 4     BCRP_sys   1.90 study 005    imaxssu 8.674701e-02      0.02  TRUE #> 5      OATP1B1 177.00 study 006 imaxinletu 1.090047e-03      0.10 FALSE #> 6      OATP1B3  35.00 study 006 imaxinletu 5.512525e-03      0.10 FALSE #> 7         OAT1 271.00              imaxssu 6.081894e-04      0.10 FALSE #> 8         OAT3 300.00              imaxssu 5.493978e-04      0.10 FALSE #> 9         BSEP  12.80              imaxssu 1.287651e-02      0.10 FALSE #> 10        OCT1   2.30 study 006       <NA>           NA        NA    NA #> 11        OCT2  67.00 study 006    imaxssu 2.459990e-03      0.10 FALSE #> 12       MATE1   3.60 study 006    imaxssu 4.578315e-02      0.02  TRUE #> 13      MATE2k   1.10 study 006    imaxssu 1.498358e-01      0.02  TRUE  transporter_inhibition_risk_table(examplinib_parent, examplinib_transporter_inhibition_data)"},{"path":"/articles/load-data.html","id":"drug-properties","dir":"Articles","previous_headings":"","what":"Drug properties","title":"Load compound-specific data","text":"functions within ddir package evaluate various DDI risks expect first argument perpetrator object contains compound properties needed calculate relevant perpetrator concentrations. following parameters required create perpetrator object:","code":""},{"path":"/articles/load-data.html","id":"input-as-data-frame","dir":"Articles","previous_headings":"Drug properties","what":"Input as data frame","title":"Load compound-specific data","text":"basic option, compound property data can hard-coded R script data frame converted perpetrator object: Note constructor function perpetrator objects expects values character type. code, strictly required fields provided, fields automatically set respective default values construction perpetrator compound.","code":"parent_data_frame <- data.frame(   param = c(\"name\", \"oral\", \"mw\", \"dose\", \"imaxss\"),   value = c(\"examplinib\", \"TRUE\", \"492.6\", \"450\", \"3530\"),   source = c(\"\", \"\", \"\", \"\", \"\") )  parent <- new_perpetrator(parent_data_frame) parent #> ----- DDI perpetrator object ----- #> name         examplinib              #> oral         TRUE                    #> mw           492.6                   #> dose         450                     #> imaxss       3530                    #> fu           1            default    #> fumic        1            default    #> rb           1            default    #> fa           1            default    #> fg           1            default    #> ka           0.1          default    #> solubility   Inf          default"},{"path":"/articles/load-data.html","id":"input-as-tribble","dir":"Articles","previous_headings":"Drug properties","what":"Input as tribble","title":"Load compound-specific data","text":"tibble package part tidyverse meta-package provides convenient function, tribble(), construct data frames row-wise fashion. renders code much readable:","code":"parent_tribble <- tribble(   ~param,   ~value,       ~source,   \"name\",   \"examplinib\", \"\",   \"oral\",   \"TRUE\",       \"\",   \"mw\",     \"492.6\",     \"\",   \"dose\",   \"450\",        \"\",   \"imaxss\", \"3530\",       \"\"  ) parent <- new_perpetrator(parent_tribble) parent #> ----- DDI perpetrator object ----- #> name         examplinib              #> oral         TRUE                    #> mw           492.6                   #> dose         450                     #> imaxss       3530                    #> fu           1            default    #> fumic        1            default    #> rb           1            default    #> fa           1            default    #> fg           1            default    #> ka           0.1          default    #> solubility   Inf          default"},{"path":"/articles/load-data.html","id":"read-from-a-csv-file","dir":"Articles","previous_headings":"Drug properties","what":"Read from a csv file","title":"Load compound-specific data","text":"Alternatively, data can also provided comma-separated values (csv) external data file, read using read_perpetrators(). csv file ‘examplinib_compounds_single.csv’ included part package demonstration purposes: code, fs::path_package(\"extdata/examplinib_compounds_single.csv\", package = \"ddir\") construct needed resolve path sample file within package structure. regular use, file name provided . csv file expected ‘long table’ format: line must start compound name, followed parameter name, value (optionally) source information. content typical compound file may look like: fields within line must separated commas. lines starting ‘#’ considered comments evaluated.","code":"parent_perpetrator <- read_perpetrators(   fs::path_package(\"extdata/examplinib_compounds_single.csv\", package = \"ddir\") ) parent_perpetrator %>%   class() #> [1] \"perpetrator\" \"data.frame\" # PARENT     # compound,  param,    value,     source     examplinib,  oral,     TRUE,     examplinib,  mw,       492.6,     examplinib,  dose,     450,       clinical dose     examplinib,  imaxss,   3530,      study 001     examplinib,  fu,       0.023,     study 002     examplinib,  fumic,    1,         default     examplinib,  rb,       1,         study 003     examplinib,  fa,       0.81,      study 003     examplinib,  fg,       1,         default     examplinib,  ka,       0.00267,   unknown"},{"path":"/articles/load-data.html","id":"read-from-a-data-chunk-within-an-r-notebook","dir":"Articles","previous_headings":"Drug properties","what":"Read from a data chunk within an R notebook","title":"Load compound-specific data","text":"DDI risk calculations done within R notebook, highly recommend keep data, code report text single Rmd document can knitted human-readable report, compound-specific data can conveniently provided form data chunks. neat feature introduced knitrdata package. text contained chunks type ‘data’ assigned -character variable name defined ‘output.var’ chunk header document rendered: Similar csv file example, content variable can read perpetrator object: Note since data read file, input string variable wrapped textConnection() construct. Also note data file contains data two different compounds, ‘examplinib’ ‘M1’. output read_perpetrators() function therefore list perpetrator objects case. find sample DDI report fictional drug ‘examplinib’ provided part ddir package uses approach. DDI assessment, feel free copy Rmd file merely replace compound-specific data obtain basic DDI report drug.","code":"library(knitrdata) ```{data output.var = \"compounds_text\", wrapper = TRUE, engine=\"data\"} # PARENT # compound,  param,    value,     source examplinib,  oral,     TRUE, examplinib,  mw,       492.6, examplinib,  dose,     450,       clinical dose examplinib,  imaxss,   3530,      study 001 examplinib,  fu,       0.023,     study 002 examplinib,  fumic,    1,         default examplinib,  rb,       1,         study 003 examplinib,  fa,       0.81,      study 003 examplinib,  fg,       1,         default examplinib,  ka,       0.00267,   unknown  # METABOLITE # compound,  param,    value,     source M1,          oral,     FALSE, M1,          mw,       506.56, M1,          dose,     NA, M1,          imaxss,   1038,      study 001 M1,          fu,       0.012,     study 002 -- 5 more lines of data ommitted -- ``` compounds <- read_perpetrators(   textConnection(compounds_text) ) compounds #> $examplinib #> ----- DDI perpetrator object ----- #> name         examplinib                    #> oral         TRUE                          #> mw           492.6                         #> dose         450          clinical dose    #> imaxss       3530         study 001        #> fu           0.023        study 002        #> fumic        1            default          #> rb           1            study 003        #> fa           0.81         study 003        #> fg           1            default          #> ka           0.00267      unknown          #> solubility   Inf          default #> $M1 #> ----- DDI perpetrator object ----- #> name         M1                    #> oral         FALSE                 #> mw           506.56                #> dose         NA                    #> imaxss       1038     study 001    #> fu           0.012    study 002    #> fumic        1        default      #> rb           1        study 002    #> fa           NA                    #> fg           NA                    #> ka           NA                    #> solubility   Inf      default"},{"path":"/articles/load-data.html","id":"enzyme-inhibition-and-induction-data","dir":"Articles","previous_headings":"","what":"Enzyme inhibition and induction data","title":"Load compound-specific data","text":"following sections describe format vitro data enzyme transporter inhibition induction need provided respective ddir functions. can use either methods load data. However, said , suggest input data chunks within R notebook document.","code":""},{"path":"/articles/load-data.html","id":"direct-cyp-inhibition-data","dir":"Articles","previous_headings":"Enzyme inhibition and induction data","what":"Direct CYP inhibition data","title":"Load compound-specific data","text":"basic_cyp_inhibition_risk() mech_stat_cyp_risk() functions (*_table() siblings) require \\(k_i\\) values direct CYP inhibition. data frame following fields expected ‘cyp_inh’ parameter functions: See sample data frame ‘examplinib’: Use read_cyp_inhibitor_data() load data csv file textConnection.","code":"examplinib_cyp_inhibition_data #>         name     cyp   ki    source #> 1 examplinib  CYP1A2   NA           #> 2 examplinib  CYP2B6   NA           #> 3 examplinib  CYP2C8   11 study 001 #> 4 examplinib  CYP2C9  0.6 study 001 #> 5 examplinib CYP2C19 0.25 study 001 #> 6 examplinib  CYP2D6   NA           #> 7 examplinib  CYP3A4 12.5 study 001 #> 8         M1  CYP2C9  4.4 study 002"},{"path":"/articles/load-data.html","id":"ugt-inhibition-data","dir":"Articles","previous_headings":"Enzyme inhibition and induction data","what":"UGT inhibition data","title":"Load compound-specific data","text":"basic_ugt_inhibition_risk() function relies vitro data direct UGT inhibition. data frame following fields expected ‘ugt_inh’ parameter functions: See sample data frame ‘examplinib’: Use read_ugt_inhibitor_data() load data csv file textConnection.","code":"examplinib_ugt_inhibition_data #>          name     ugt ic50    source #> 1  examplinib  UGT1A1   15 study 009 #> 2  examplinib  UGT1A3   15 study 009 #> 3  examplinib  UGT1A4   15 study 009 #> 4  examplinib  UGT1A6   15 study 009 #> 5  examplinib  UGT1A9  3.8 study 009 #> 6  examplinib  UGT2B7   15 study 009 #> 7  examplinib UGT2B15   15 study 009 #> 8  examplinib UGT2B17  6.1 study 009 #> 9          M1  UGT1A1  1.1 study 009 #> 10         M1  UGT1A3  5.8 study 009 #> 11         M1  UGT1A4  6.2 study 009 #> 12         M1  UGT1A6   15 study 009 #> 13         M1  UGT1A9  3.6 study 009 #> 14         M1  UGT2B7   15 study 009 #> 15         M1 UGT2B15  9.6 study 009 #> 16         M1 UGT2B17  2.2 study 009"},{"path":"/articles/load-data.html","id":"time-dependent-cyp-inhibition-tdi-data","dir":"Articles","previous_headings":"Enzyme inhibition and induction data","what":"Time-dependent CYP inhibition (TDI) data","title":"Load compound-specific data","text":"basic_cyp_tdi_risk() mech_stat_cyp_risk() functions (*_table() siblings) rely vitro data TDI. data frame fields expected ‘cyp_tdi’ parameter functions: See sample data frame ‘examplinib’: Use read_tdi_data() load data csv file textConnection.","code":"examplinib_cyp_tdi_data #>         name    cyp   ki kinact    source #> 1 examplinib CYP3A4 0.17   0.04 study 001"},{"path":"/articles/load-data.html","id":"cyp-induction-data","dir":"Articles","previous_headings":"Enzyme inhibition and induction data","what":"CYP induction data","title":"Load compound-specific data","text":"static_cyp_induction_risk(), kinetic_cyp_induction_risk() mech_stat_cyp_risk() functions (*_table() siblings) rely vitro data CYP induction. data frame fields expected ‘cyp_ind’ parameter functions: See sample data frame ‘examplinib’: Use read_inducer_data() load data csv file textConnection.","code":"examplinib_cyp_induction_data #>          name     cyp  emax ec50 maxc    source #> 1  examplinib  CYP1A2  1.00   NA    5 study 007 #> 2  examplinib  CYP2B6  1.00   NA    5 study 007 #> 3  examplinib  CYP2C8    NA   NA   NA           #> 4  examplinib  CYP2C9    NA   NA   NA           #> 5  examplinib CYP2C19    NA   NA   NA           #> 6  examplinib  CYP2D6    NA   NA   NA           #> 7  examplinib  CYP3A4  7.35 1.64    3 study 007 #> 8          M1  CYP1A2  1.00   NA    5 study 007 #> 9          M1  CYP2B6  6.98 1.86    5 study 007 #> 10         M1  CYP2C8    NA   NA   NA           #> 11         M1  CYP2C9    NA   NA   NA           #> 12         M1 CYP2C19    NA   NA   NA           #> 13         M1  CYP2D6    NA   NA   NA           #> 14         M1  CYP3A4 22.70 1.10    5 study 007"},{"path":"/articles/load-data.html","id":"transporter-inhibition-data","dir":"Articles","previous_headings":"","what":"Transporter inhibition data","title":"Load compound-specific data","text":"transporter_inhibition_risk() function relies vitro data direct transporter inhibition provided data frame ‘transporter_inh’ parameter. following fields expected: See sample data frame ‘examplinib’: Use read_transporter_inhibitor_data() load data csv file textConnection.","code":"examplinib_transporter_inhibition_data #>          name transporter ic50    source #> 1  examplinib         Pgp 0.41 study 005 #> 2  examplinib        BCRP  1.9 study 005 #> 3  examplinib        OCT1  2.3 study 006 #> 4  examplinib     OATP1B1  177 study 006 #> 5  examplinib     OATP1B3   35 study 006 #> 6  examplinib        OAT1  271           #> 7  examplinib        OAT3  300           #> 8  examplinib        BSEP 12.8           #> 9  examplinib        OCT2   67 study 006 #> 10 examplinib       MATE1  3.6 study 006 #> 11 examplinib      MATE2k  1.1 study 006"},{"path":"/authors.html","id":null,"dir":"","previous_headings":"","what":"Authors","title":"Authors and Citation","text":"Rainer Strotmann. Maintainer.","code":""},{"path":"/authors.html","id":"citation","dir":"","previous_headings":"","what":"Citation","title":"Authors and Citation","text":"Strotmann R (2024). ddir: Assess Clinical Drug-Drug Interaction Risk Drug Compounds. R package version 0.15.3.","code":"@Manual{,   title = {ddir: Assess the Clinical Drug-Drug Interaction Risk for Drug Compounds},   author = {Rainer Strotmann},   year = {2024},   note = {R package version 0.15.3}, }"},{"path":"/index.html","id":"ddir","dir":"","previous_headings":"","what":"Assess the Clinical Drug-Drug Interaction Risk for Drug Compounds","title":"Assess the Clinical Drug-Drug Interaction Risk for Drug Compounds","text":"package provides functions calculation documentation potential drugs act perpetrators clinically relevant drug-drug interaction (DDI).","code":""},{"path":"/index.html","id":"installation","dir":"","previous_headings":"","what":"Installation","title":"Assess the Clinical Drug-Drug Interaction Risk for Drug Compounds","text":"can install development version ddir like :","code":"devtools::install_github(\"rstrotmann/ddir\")"},{"path":"/index.html","id":"example","dir":"","previous_headings":"","what":"Example","title":"Assess the Clinical Drug-Drug Interaction Risk for Drug Compounds","text":"package provides sample data fictional drug, examplinib. following code shows relevant drug properties examplinib, calculates perpetrator DDI risk direct CYP inhibition (basic method). provided markdown-formatted output tables: Compound parameters examplinib Risk direct CYP inhibition examplinib (basic model) See also: kinetic_cyp_induction_risk_table(), mech_stat_cyp_risk_table(), basic_ugt_inhibition_risk_table(), transporter_inhibition_risk_table()","code":"library(ddir)  p <- examplinib_parent property_table(p) basic_cyp_inhibition_risk_table(p, examplinib_cyp_inhibition_data)"},{"path":"/index.html","id":"full-ddi-perpetrator-report","dir":"","previous_headings":"","what":"Full DDI perpetrator report","title":"Assess the Clinical Drug-Drug Interaction Risk for Drug Compounds","text":"easy starting point full DDI perpetrator report, load sample DDI report package source github, replace compound-specific data data drug, knit() Word pdf document. Full documentation ddir can found together source code github.","code":""},{"path":"/reference/basic_cyp_inhibition_risk.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"function evaluates clinical risk direct (reversible) CYP inhibition according basic model defined relevant regulatory guideline.","code":""},{"path":"/reference/basic_cyp_inhibition_risk.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"","code":"basic_cyp_inhibition_risk(perp, cyp_inh)"},{"path":"/reference/basic_cyp_inhibition_risk.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"perp perpetrator object. cyp_inh CYP inhibition data data frame. following fields expected: 'name' name perpetrator compound. 'cyp' CYP enzyme (upper case) character. 'ki' \\(K_i\\) \\(\\mu M\\) numeric. 'source' Optional source information character.","code":""},{"path":"/reference/basic_cyp_inhibition_risk.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"data frame.","code":""},{"path":"/reference/basic_cyp_inhibition_risk.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"basic modeling direct (reversible) CYP enzyme inhibition, ratio relevant inhibitor concentration \\(K_i\\) respective CYP enzyme considered, .e., \\(R\\) hepatic enzymes \\(R_{gut}\\) intestinal enzymes (refer Section 2.1.2.1 ICH M12 guidance document).","code":""},{"path":"/reference/basic_cyp_inhibition_risk.html","id":"liver","dir":"Reference","previous_headings":"","what":"Liver","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"$$R=\\frac{C_{max,ss,u}}{K_{,u}}$$ \\(R\\) values > 0.02, .e., maximal unbound perpetrator concentrations 50-fold \\(K_i\\) considered indicate potential clinical CYP inhibition risk using method.","code":""},{"path":"/reference/basic_cyp_inhibition_risk.html","id":"intestine","dir":"Reference","previous_headings":"","what":"Intestine","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"$$R_{gut}=\\frac{I_{gut}}{K_{,u}}$$ $$I_{gut}=\\frac{Dose}{250\\ mg}$$ \\(R\\) values > 10 considered indicate clinical risk intestinal CYP3A inhibition. output, columns risk_hep risk_intest indicate whether regulatory threshold reached respective enzyme.","code":""},{"path":[]},{"path":"/reference/basic_cyp_inhibition_risk.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"","code":"basic_cyp_inhibition_risk(examplinib_parent, examplinib_cyp_inhibition_data) #>       cyp    ki   kiu      r risk_hep    r_gut risk_intest #> 1  CYP1A2    NA    NA     NA       NA       NA          NA #> 2  CYP2B6    NA    NA     NA       NA       NA          NA #> 3  CYP2C8 11.00 11.00 0.0150    FALSE       NA          NA #> 4  CYP2C9  0.60  0.60 0.2747     TRUE       NA          NA #> 5 CYP2C19  0.25  0.25 0.6593     TRUE       NA          NA #> 6  CYP2D6    NA    NA     NA       NA       NA          NA #> 7  CYP3A4 12.50 12.50 0.0132    FALSE 292.3264        TRUE"},{"path":"/reference/basic_cyp_inhibition_risk_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic CYP inhibition risk table — basic_cyp_inhibition_risk_table","title":"Basic CYP inhibition risk table — basic_cyp_inhibition_risk_table","text":"function generates markdown-formatted table direct (reversible) CYP inhibition risk assessment. See basic_cyp_inhibition_risk() details calculation risk.","code":""},{"path":"/reference/basic_cyp_inhibition_risk_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic CYP inhibition risk table — basic_cyp_inhibition_risk_table","text":"","code":"basic_cyp_inhibition_risk_table(   perp,   cyp_inh,   na.rm = FALSE,   show_dose = FALSE )"},{"path":"/reference/basic_cyp_inhibition_risk_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic CYP inhibition risk table — basic_cyp_inhibition_risk_table","text":"perp perpetrator object. cyp_inh CYP inhibition data data frame. following fields expected: 'name' name perpetrator compound. 'cyp' CYP enzyme (upper case) character. 'ki' \\(K_i\\) \\(\\mu M\\) numeric. 'source' Optional source information character. na.rm Switch define whether rows lacking \\(K_i\\) data removed output (.e., ki == NA). Defaults FALSE. show_dose Show perpetrator dose table title, defaults FALSE.","code":""},{"path":"/reference/basic_cyp_inhibition_risk_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic CYP inhibition risk table — basic_cyp_inhibition_risk_table","text":"markdown-formatted table, empty string.","code":""},{"path":[]},{"path":"/reference/basic_cyp_inhibition_risk_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic CYP inhibition risk table — basic_cyp_inhibition_risk_table","text":"","code":"basic_cyp_inhibition_risk_table(examplinib_parent,   examplinib_cyp_inhibition_data) #>  #>  #> Table: Risk for direct CYP inhibition by examplinib, basic model #>  #> |CYP     | $K_{i}$ ($\\mu M$)| $K_{i,u}$ ($\\mu M$)|   $R$|risk (hepatic) |$R_{gut}$ |risk (intestinal) | #> |:-------|-----------------:|-------------------:|-----:|:--------------|:---------|:-----------------| #> |CYP1A2  |                NA|                  NA|    NA|               |          |                  | #> |CYP2B6  |                NA|                  NA|    NA|               |          |                  | #> |CYP2C8  |             11.00|               11.00| 0.015|No             |          |                  | #> |CYP2C9  |              0.60|                0.60| 0.275|Yes            |          |                  | #> |CYP2C19 |              0.25|                0.25| 0.659|Yes            |          |                  | #> |CYP2D6  |                NA|                  NA|    NA|               |          |                  | #> |CYP3A4  |             12.50|               12.50| 0.013|No             |292.3     |Yes               | basic_cyp_inhibition_risk_table(examplinib_compounds,   examplinib_cyp_inhibition_data, na.rm = TRUE) #>  #>  #> Table: Risk for direct CYP inhibition by examplinib, basic model #>  #> |CYP     | $K_{i}$ ($\\mu M$)| $K_{i,u}$ ($\\mu M$)|   $R$|risk (hepatic) |$R_{gut}$ |risk (intestinal) | #> |:-------|-----------------:|-------------------:|-----:|:--------------|:---------|:-----------------| #> |CYP2C8  |             11.00|               11.00| 0.015|No             |          |                  | #> |CYP2C9  |              0.60|                0.60| 0.275|Yes            |          |                  | #> |CYP2C19 |              0.25|                0.25| 0.659|Yes            |          |                  | #> |CYP3A4  |             12.50|               12.50| 0.013|No             |292.3     |Yes               | #>  #>  #> Table: Risk for direct CYP inhibition by M1, basic model #>  #> |CYP    | $K_{i}$ ($\\mu M$)| $K_{i,u}$ ($\\mu M$)|   $R$|risk (hepatic) |$R_{gut}$ |risk (intestinal) | #> |:------|-----------------:|-------------------:|-----:|:--------------|:---------|:-----------------| #> |CYP2C9 |               4.4|                 4.4| 0.006|No             |          |                  | basic_cyp_inhibition_risk_table(examplinib_compounds,   examplinib_cyp_inhibition_data, na.rm = TRUE, show_dose = TRUE) #>  #>  #> Table: Risk for direct CYP inhibition by examplinib (450 mg), basic model #>  #> |CYP     | $K_{i}$ ($\\mu M$)| $K_{i,u}$ ($\\mu M$)|   $R$|risk (hepatic) |$R_{gut}$ |risk (intestinal) | #> |:-------|-----------------:|-------------------:|-----:|:--------------|:---------|:-----------------| #> |CYP2C8  |             11.00|               11.00| 0.015|No             |          |                  | #> |CYP2C9  |              0.60|                0.60| 0.275|Yes            |          |                  | #> |CYP2C19 |              0.25|                0.25| 0.659|Yes            |          |                  | #> |CYP3A4  |             12.50|               12.50| 0.013|No             |292.3     |Yes               | #>  #>  #> Table: Risk for direct CYP inhibition by M1, basic model #>  #> |CYP    | $K_{i}$ ($\\mu M$)| $K_{i,u}$ ($\\mu M$)|   $R$|risk (hepatic) |$R_{gut}$ |risk (intestinal) | #> |:------|-----------------:|-------------------:|-----:|:--------------|:---------|:-----------------| #> |CYP2C9 |               4.4|                 4.4| 0.006|No             |          |                  |"},{"path":"/reference/basic_cyp_tdi_risk.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic modeling of the CYP time-dependent inhibition risk — basic_cyp_tdi_risk","title":"Basic modeling of the CYP time-dependent inhibition risk — basic_cyp_tdi_risk","text":"function calculates risk time-dependent inhibition CYP enzymes.","code":""},{"path":"/reference/basic_cyp_tdi_risk.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic modeling of the CYP time-dependent inhibition risk — basic_cyp_tdi_risk","text":"","code":"basic_cyp_tdi_risk(perp, cyp_tdi, cyp_kdeg = cyp_turnover)"},{"path":"/reference/basic_cyp_tdi_risk.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic modeling of the CYP time-dependent inhibition risk — basic_cyp_tdi_risk","text":"perp perpetrator object. cyp_tdi CYP TDI data data frame. following fields expected: 'name' perpetrator compound name character. 'cyp' CYP enzyme character. 'ki' \\(K_I\\) \\(\\mu M\\) numeric. 'kinact' \\(k_{inact}\\) 1/h numeric. 'source' Optional source information character, cyp_kdeg CYP turnover data data frame. Defaults built-reference data, cyp_turnover.","code":""},{"path":"/reference/basic_cyp_tdi_risk.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic modeling of the CYP time-dependent inhibition risk — basic_cyp_tdi_risk","text":"data frame.","code":""},{"path":"/reference/basic_cyp_tdi_risk.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Basic modeling of the CYP time-dependent inhibition risk — basic_cyp_tdi_risk","text":"risk assessment based : $$R=\\frac {k_{obs} + k_{deg}}{k_{deg}}$$ $$k_{obs}=\\frac {5*k_{inact}*C_{max,u}}{K_{,u} + 5 * C_{max,u}}$$ Values \\(R > 1.25\\) suggest relevant TDI potential. CYP degradation rates, \\(k_{deg}\\) physiological constants derived scientific literature. package provides standard values \\(k_{deg}\\) cyp_turnover commonly used. present version, risk hepatic TDI CYP enzymes calculated.","code":""},{"path":[]},{"path":"/reference/basic_cyp_tdi_risk.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic modeling of the CYP time-dependent inhibition risk — basic_cyp_tdi_risk","text":"","code":"basic_cyp_tdi_risk(examplinib_parent, examplinib_cyp_tdi_data) #>      cyp   ki    fu kinact   kdeg    source        r risk #> 1 CYP3A4 0.17 0.023   0.04 0.0193 study 001 3.062752 TRUE"},{"path":"/reference/basic_cyp_tdi_risk_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic CYP time-dependent inhibition risk table — basic_cyp_tdi_risk_table","title":"Basic CYP time-dependent inhibition risk table — basic_cyp_tdi_risk_table","text":"Basic CYP time-dependent inhibition risk table","code":""},{"path":"/reference/basic_cyp_tdi_risk_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic CYP time-dependent inhibition risk table — basic_cyp_tdi_risk_table","text":"","code":"basic_cyp_tdi_risk_table(   perp,   cyp_tdi,   cyp_kdeg = cyp_turnover,   na.rm = TRUE,   show_dose = FALSE )"},{"path":"/reference/basic_cyp_tdi_risk_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic CYP time-dependent inhibition risk table — basic_cyp_tdi_risk_table","text":"perp perpetrator object. cyp_tdi CYP TDI data data frame. following fields expected: 'name' perpetrator compound name character. 'cyp' CYP enzyme character. 'ki' \\(K_I\\) \\(\\mu M\\) numeric. 'kinact' \\(k_{inact}\\) 1/h numeric. 'source' Optional source information character, cyp_kdeg CYP turnover data data frame. Defaults built-reference data, cyp_turnover. na.rm Switch define whether rows lacking \\(K_i\\) data removed output. Defaults FALSE. show_dose Show perpetrator dose table title, defaults FALSE.","code":""},{"path":"/reference/basic_cyp_tdi_risk_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic CYP time-dependent inhibition risk table — basic_cyp_tdi_risk_table","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/basic_cyp_tdi_risk_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic CYP time-dependent inhibition risk table — basic_cyp_tdi_risk_table","text":"","code":"basic_cyp_tdi_risk_table(examplinib_parent, examplinib_cyp_tdi_data) #>  #>  #> Table: Risk for CYP TDI by examplinib, basic model #>  #> |CYP    | $K_{I}$ ($\\mu M$)| $f_u$| $k_{inact}$ (1/h)| $k_{deg}$ (1/h)|source    |  $R$|risk | #> |:------|-----------------:|-----:|-----------------:|---------------:|:---------|----:|:----| #> |CYP3A4 |              0.17|  0.02|              0.04|            0.02|study 001 | 3.06|Yes  | basic_cyp_tdi_risk_table(examplinib_compounds, examplinib_cyp_tdi_data) #>  #>  #> Table: Risk for CYP TDI by examplinib, basic model #>  #> |CYP    | $K_{I}$ ($\\mu M$)| $f_u$| $k_{inact}$ (1/h)| $k_{deg}$ (1/h)|source    |  $R$|risk | #> |:------|-----------------:|-----:|-----------------:|---------------:|:---------|----:|:----| #> |CYP3A4 |              0.17|  0.02|              0.04|            0.02|study 001 | 3.06|Yes  | basic_cyp_tdi_risk_table(examplinib_compounds, examplinib_cyp_tdi_data,   show_dose = TRUE) #>  #>  #> Table: Risk for CYP TDI by examplinib (450 mg), basic model #>  #> |CYP    | $K_{I}$ ($\\mu M$)| $f_u$| $k_{inact}$ (1/h)| $k_{deg}$ (1/h)|source    |  $R$|risk | #> |:------|-----------------:|-----:|-----------------:|---------------:|:---------|----:|:----| #> |CYP3A4 |              0.17|  0.02|              0.04|            0.02|study 001 | 3.06|Yes  |"},{"path":"/reference/basic_ugt_inhibition_risk.html","id":null,"dir":"Reference","previous_headings":"","what":"UGT inhibition risk — basic_ugt_inhibition_risk","title":"UGT inhibition risk — basic_ugt_inhibition_risk","text":"function evaluates clinical risk reversible inhibition UGT enzymes according relevant regulatory guideline.","code":""},{"path":"/reference/basic_ugt_inhibition_risk.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"UGT inhibition risk — basic_ugt_inhibition_risk","text":"","code":"basic_ugt_inhibition_risk(perp, ugt_inh)"},{"path":"/reference/basic_ugt_inhibition_risk.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"UGT inhibition risk — basic_ugt_inhibition_risk","text":"perp perpetrator object. ugt_inh UGT inhibition data data frame, following fields expected: 'name' name perpetrator compound. 'ugt' UGT enzyme (upper case) character. 'ic50' \\(IC_{50}\\) \\(\\mu M\\) numeric. 'source' Optional source information character.","code":""},{"path":"/reference/basic_ugt_inhibition_risk.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"UGT inhibition risk — basic_ugt_inhibition_risk","text":"markdown-formatted table.","code":""},{"path":"/reference/basic_ugt_inhibition_risk.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"UGT inhibition risk — basic_ugt_inhibition_risk","text":"function assumes UGT inhibition data provided \\(IC_{50}\\). According Cheng, Prusoff 1973), \\(K_i\\) can assumed \\(IC_{50}/2\\) experimental conditions commonly used vitro inhibition studies substrate concentrations close \\(K_M\\). relevant metric basic modeling UGT inhibition risk \\(R=C_{max,ss,u}/K_{,u}\\) Refer Section 2.1.2.1 ICH M12 guidance document) details. \\(R>0.02\\) considered indicate potential UGT inhibition risk.","code":""},{"path":[]},{"path":"/reference/basic_ugt_inhibition_risk.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"UGT inhibition risk — basic_ugt_inhibition_risk","text":"","code":"basic_ugt_inhibition_risk(examplinib_parent, examplinib_ugt_inhibition_data) #>       ugt  kiu          r risk #> 1  UGT1A1 7.50 0.02197591 TRUE #> 2  UGT1A3 7.50 0.02197591 TRUE #> 3  UGT1A4 7.50 0.02197591 TRUE #> 4  UGT1A6 7.50 0.02197591 TRUE #> 5  UGT1A9 1.90 0.08674701 TRUE #> 6  UGT2B7 7.50 0.02197591 TRUE #> 7 UGT2B15 7.50 0.02197591 TRUE #> 8 UGT2B17 3.05 0.05403912 TRUE"},{"path":"/reference/basic_ugt_inhibition_risk_table.html","id":null,"dir":"Reference","previous_headings":"","what":"UGT inhibition risk table — basic_ugt_inhibition_risk_table","title":"UGT inhibition risk table — basic_ugt_inhibition_risk_table","text":"function generates markdown-formatted table reversible UGT inhibition risk assessment. See basic_ugt_inhibition_risk() details calculation risk.","code":""},{"path":"/reference/basic_ugt_inhibition_risk_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"UGT inhibition risk table — basic_ugt_inhibition_risk_table","text":"","code":"basic_ugt_inhibition_risk_table(perp, ugt_inh, na.rm = F, show_dose = FALSE)"},{"path":"/reference/basic_ugt_inhibition_risk_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"UGT inhibition risk table — basic_ugt_inhibition_risk_table","text":"perp perpetrator object. ugt_inh UGT inhibition data data frame, following fields expected: 'name' name perpetrator compound. 'ugt' UGT enzyme (upper case) character. 'ic50' \\(IC_{50}\\) \\(\\mu M\\) numeric. 'source' Optional source information character. na.rm Boolean define whether rows lacking \\(K_i\\) data removed output (.e., ki == NA). show_dose Show_dose Show perpetrator dose table title, defaults FALSE.","code":""},{"path":"/reference/basic_ugt_inhibition_risk_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"UGT inhibition risk table — basic_ugt_inhibition_risk_table","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/basic_ugt_inhibition_risk_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"UGT inhibition risk table — basic_ugt_inhibition_risk_table","text":"","code":"basic_ugt_inhibition_risk_table(examplinib_parent,   examplinib_ugt_inhibition_data) #>  #>  #> Table: Risk for UGT inhibition by examplinib, basic model #>  #> |UGT     | $K_{i,u}$|   $R$|risk | #> |:-------|---------:|-----:|:----| #> |UGT1A1  |      7.50| 0.022|Yes  | #> |UGT1A3  |      7.50| 0.022|Yes  | #> |UGT1A4  |      7.50| 0.022|Yes  | #> |UGT1A6  |      7.50| 0.022|Yes  | #> |UGT1A9  |      1.90| 0.087|Yes  | #> |UGT2B7  |      7.50| 0.022|Yes  | #> |UGT2B15 |      7.50| 0.022|Yes  | #> |UGT2B17 |      3.05| 0.054|Yes  | basic_ugt_inhibition_risk_table(examplinib_compounds,   examplinib_ugt_inhibition_data) #>  #>  #> Table: Risk for UGT inhibition by examplinib, basic model #>  #> |UGT     | $K_{i,u}$|   $R$|risk | #> |:-------|---------:|-----:|:----| #> |UGT1A1  |      7.50| 0.022|Yes  | #> |UGT1A3  |      7.50| 0.022|Yes  | #> |UGT1A4  |      7.50| 0.022|Yes  | #> |UGT1A6  |      7.50| 0.022|Yes  | #> |UGT1A9  |      1.90| 0.087|Yes  | #> |UGT2B7  |      7.50| 0.022|Yes  | #> |UGT2B15 |      7.50| 0.022|Yes  | #> |UGT2B17 |      3.05| 0.054|Yes  | #>  #>  #> Table: Risk for UGT inhibition by M1, basic model #>  #> |UGT     | $K_{i,u}$|   $R$|risk | #> |:-------|---------:|-----:|:----| #> |UGT1A1  |      0.55| 0.045|Yes  | #> |UGT1A3  |      2.90| 0.008|No   | #> |UGT1A4  |      3.10| 0.008|No   | #> |UGT1A6  |      7.50| 0.003|No   | #> |UGT1A9  |      1.80| 0.014|No   | #> |UGT2B7  |      7.50| 0.003|No   | #> |UGT2B15 |      4.80| 0.005|No   | #> |UGT2B17 |      1.10| 0.022|Yes  | basic_ugt_inhibition_risk_table(examplinib_compounds,   examplinib_ugt_inhibition_data, show_dose = TRUE) #>  #>  #> Table: Risk for UGT inhibition by examplinib (450 mg), basic model #>  #> |UGT     | $K_{i,u}$|   $R$|risk | #> |:-------|---------:|-----:|:----| #> |UGT1A1  |      7.50| 0.022|Yes  | #> |UGT1A3  |      7.50| 0.022|Yes  | #> |UGT1A4  |      7.50| 0.022|Yes  | #> |UGT1A6  |      7.50| 0.022|Yes  | #> |UGT1A9  |      1.90| 0.087|Yes  | #> |UGT2B7  |      7.50| 0.022|Yes  | #> |UGT2B15 |      7.50| 0.022|Yes  | #> |UGT2B17 |      3.05| 0.054|Yes  | #>  #>  #> Table: Risk for UGT inhibition by M1, basic model #>  #> |UGT     | $K_{i,u}$|   $R$|risk | #> |:-------|---------:|-----:|:----| #> |UGT1A1  |      0.55| 0.045|Yes  | #> |UGT1A3  |      2.90| 0.008|No   | #> |UGT1A4  |      3.10| 0.008|No   | #> |UGT1A6  |      7.50| 0.003|No   | #> |UGT1A9  |      1.80| 0.014|No   | #> |UGT2B7  |      7.50| 0.003|No   | #> |UGT2B15 |      4.80| 0.005|No   | #> |UGT2B17 |      1.10| 0.022|Yes  |"},{"path":"/reference/compound_names_string.html","id":null,"dir":"Reference","previous_headings":"","what":"Compound names as single string — compound_names_string","title":"Compound names as single string — compound_names_string","text":"function returns single string names perpetrator compounds listed nicely.","code":""},{"path":"/reference/compound_names_string.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Compound names as single string — compound_names_string","text":"","code":"compound_names_string(compounds)"},{"path":"/reference/compound_names_string.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Compound names as single string — compound_names_string","text":"compounds list perpetrator objects","code":""},{"path":"/reference/compound_names_string.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Compound names as single string — compound_names_string","text":"character string.","code":""},{"path":"/reference/compound_names_string.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Compound names as single string — compound_names_string","text":"","code":"compound_names_string(examplinib_compounds) #> [1] \"examplinib and M1\""},{"path":"/reference/conc_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of key perpetrator concentrations — conc_table","title":"Table of key perpetrator concentrations — conc_table","text":"function generates markdown-formatted table key perpetrator concentrations used assessment DDI perpetrator potential. See key_concentrations() details calculation.","code":""},{"path":"/reference/conc_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of key perpetrator concentrations — conc_table","text":"","code":"conc_table(perp, show_dose = FALSE)"},{"path":"/reference/conc_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of key perpetrator concentrations — conc_table","text":"perp perpetrator object list perpetrator objects. show_dose Show perpetrator dose table title, defaults FALSE.","code":""},{"path":"/reference/conc_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of key perpetrator concentrations — conc_table","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/conc_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of key perpetrator concentrations — conc_table","text":"","code":"conc_table(examplinib_parent) #>  #>  #> Table: Key perpetrator concentrations for examplinib #>  #> |parameter            |value (ng/ml) |value (uM) | #> |:--------------------|:-------------|:----------| #> |$I_{gut}$            |1800000.0     |3654.080   | #> |$I_{max,ss,u}$       |81.2          |0.165      | #> |$I_{max,inlet,u}$    |95.0          |0.193      | #> |$I_{max,intestinal}$ |3244.1        |6.586      | conc_table(examplinib_compounds) #>  #>  #> Table: Key perpetrator concentrations for examplinib #>  #> |parameter            |value (ng/ml) |value (uM) | #> |:--------------------|:-------------|:----------| #> |$I_{gut}$            |1800000.0     |3654.080   | #> |$I_{max,ss,u}$       |81.2          |0.165      | #> |$I_{max,inlet,u}$    |95.0          |0.193      | #> |$I_{max,intestinal}$ |3244.1        |6.586      | #>  #>  #> Table: Key perpetrator concentrations for M1 #>  #> |parameter            |value (ng/ml) |value (uM) | #> |:--------------------|:-------------|:----------| #> |$I_{gut}$            |0.0           |0.0000     | #> |$I_{max,ss,u}$       |12.5          |0.0246     | #> |$I_{max,inlet,u}$    |12.5          |0.0246     | #> |$I_{max,intestinal}$ |12.5          |0.0246     | conc_table(examplinib_compounds, show_dose = TRUE) #>  #>  #> Table: Key perpetrator concentrations for examplinib (450 mg) #>  #> |parameter            |value (ng/ml) |value (uM) | #> |:--------------------|:-------------|:----------| #> |$I_{gut}$            |1800000.0     |3654.080   | #> |$I_{max,ss,u}$       |81.2          |0.165      | #> |$I_{max,inlet,u}$    |95.0          |0.193      | #> |$I_{max,intestinal}$ |3244.1        |6.586      | #>  #>  #> Table: Key perpetrator concentrations for M1 #>  #> |parameter            |value (ng/ml) |value (uM) | #> |:--------------------|:-------------|:----------| #> |$I_{gut}$            |0.0           |0.0000     | #> |$I_{max,ss,u}$       |12.5          |0.0246     | #> |$I_{max,inlet,u}$    |12.5          |0.0246     | #> |$I_{max,intestinal}$ |12.5          |0.0246     |"},{"path":"/reference/conditional_dose_string.html","id":null,"dir":"Reference","previous_headings":"","what":"Perpetrator dose as string — conditional_dose_string","title":"Perpetrator dose as string — conditional_dose_string","text":"Perpetrator dose string","code":""},{"path":"/reference/conditional_dose_string.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Perpetrator dose as string — conditional_dose_string","text":"","code":"conditional_dose_string(perp, show_dose = TRUE)"},{"path":"/reference/conditional_dose_string.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Perpetrator dose as string — conditional_dose_string","text":"perp perpetrator object. show_dose Show dose logical.","code":""},{"path":"/reference/conditional_dose_string.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Perpetrator dose as string — conditional_dose_string","text":"Character string.","code":""},{"path":"/reference/conditional_dose_string.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Perpetrator dose as string — conditional_dose_string","text":"","code":"conditional_dose_string(examplinib_parent, TRUE) #> [1] \" (450 mg)\" conditional_dose_string(examplinib_metabolite, TRUE) conditional_dose_string(examplinib_parent, FALSE)"},{"path":"/reference/cyp_induction_risk_summary.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary statement for CYP induction — cyp_induction_risk_summary","title":"Summary statement for CYP induction — cyp_induction_risk_summary","text":"Summary statement CYP induction","code":""},{"path":"/reference/cyp_induction_risk_summary.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary statement for CYP induction — cyp_induction_risk_summary","text":"","code":"cyp_induction_risk_summary(perp, cyp_ind, d = 1)"},{"path":"/reference/cyp_induction_risk_summary.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary statement for CYP induction — cyp_induction_risk_summary","text":"perp perpetrator object list thereof. cyp_ind CYP induction data data frame. following fields expected: 'name' name perpetrator compound character. 'cyp' CYP enzyme (upper case) character. 'emax' \\(E_{max}\\), .e., maximum induction effect determined vitro numeric. 'ec50' \\(EC_{50}\\) \\(\\mu M\\) numeric. 'maxc' maximal concentration \\(\\mu M\\) tested vitro assay numeric. 'source' Optional source information character. d Scaling factor, defaults 1.","code":""},{"path":"/reference/cyp_induction_risk_summary.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary statement for CYP induction — cyp_induction_risk_summary","text":"Markdown-formatted text output.","code":""},{"path":"/reference/cyp_induction_risk_summary.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary statement for CYP induction for a list of precipitants — cyp_induction_risk_summary.list","title":"Summary statement for CYP induction for a list of precipitants — cyp_induction_risk_summary.list","text":"Summary statement CYP induction list precipitants","code":""},{"path":"/reference/cyp_induction_risk_summary.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary statement for CYP induction for a list of precipitants — cyp_induction_risk_summary.list","text":"","code":"# S3 method for class 'list' cyp_induction_risk_summary(perp, ...)"},{"path":"/reference/cyp_induction_risk_summary.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary statement for CYP induction for a list of precipitants — cyp_induction_risk_summary.list","text":"perp list perpetrator objects. ... arguments.","code":""},{"path":"/reference/cyp_induction_risk_summary.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary statement for CYP induction for a list of precipitants — cyp_induction_risk_summary.list","text":"Markdown-formatted text output.","code":""},{"path":"/reference/cyp_induction_risk_summary.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary statement for CYP induction for a precipitant compound — cyp_induction_risk_summary.perpetrator","title":"Summary statement for CYP induction for a precipitant compound — cyp_induction_risk_summary.perpetrator","text":"Summary statement CYP induction precipitant compound","code":""},{"path":"/reference/cyp_induction_risk_summary.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary statement for CYP induction for a precipitant compound — cyp_induction_risk_summary.perpetrator","text":"","code":"# S3 method for class 'perpetrator' cyp_induction_risk_summary(perp, cyp_ind, d = 1)"},{"path":"/reference/cyp_induction_risk_summary.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary statement for CYP induction for a precipitant compound — cyp_induction_risk_summary.perpetrator","text":"perp perpetrator object list thereof. cyp_ind CYP induction data data frame. following fields expected: 'name' name perpetrator compound character. 'cyp' CYP enzyme (upper case) character. 'emax' \\(E_{max}\\), .e., maximum induction effect determined vitro numeric. 'ec50' \\(EC_{50}\\) \\(\\mu M\\) numeric. 'maxc' maximal concentration \\(\\mu M\\) tested vitro assay numeric. 'source' Optional source information character. d Scaling factor, defaults 1.","code":""},{"path":"/reference/cyp_induction_risk_summary.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary statement for CYP induction for a precipitant compound — cyp_induction_risk_summary.perpetrator","text":"Markdown-formatted text output.","code":""},{"path":"/reference/cyp_inhibition_risk_summary.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary statement for CYP inhibition — cyp_inhibition_risk_summary","title":"Summary statement for CYP inhibition — cyp_inhibition_risk_summary","text":"Summary statement CYP inhibition","code":""},{"path":"/reference/cyp_inhibition_risk_summary.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary statement for CYP inhibition — cyp_inhibition_risk_summary","text":"","code":"cyp_inhibition_risk_summary(perp, cyp_inh)"},{"path":"/reference/cyp_inhibition_risk_summary.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary statement for CYP inhibition — cyp_inhibition_risk_summary","text":"perp perpetrator object. cyp_inh CYP inhibition data data frame. following fields expected: 'name' name perpetrator compound. 'cyp' CYP enzyme (upper case) character. 'ki' \\(K_i\\) \\(\\mu M\\) numeric. 'source' Optional source information character.","code":""},{"path":"/reference/cyp_inhibition_risk_summary.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary statement for CYP inhibition — cyp_inhibition_risk_summary","text":"Markdown-formatted text output.","code":""},{"path":"/reference/cyp_inhibition_risk_summary.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Summary statement for CYP inhibition — cyp_inhibition_risk_summary","text":"","code":"cyp_inhibition_risk_summary(examplinib_parent, examplinib_cyp_inhibition_data) #> [1] \"* examplinib has a clinical risk for direct inhibition of CYP2C9 and CYP2C19 (basic modeling)\" cyp_inhibition_risk_summary(examplinib_compounds, examplinib_cyp_inhibition_data) #> [1] \"* examplinib has a clinical risk for direct inhibition of CYP2C9 and CYP2C19 (basic modeling)\""},{"path":"/reference/cyp_inhibition_risk_summary.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary statement for CYP inhibition for a list of perpetrators — cyp_inhibition_risk_summary.list","title":"Summary statement for CYP inhibition for a list of perpetrators — cyp_inhibition_risk_summary.list","text":"Summary statement CYP inhibition list perpetrators","code":""},{"path":"/reference/cyp_inhibition_risk_summary.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary statement for CYP inhibition for a list of perpetrators — cyp_inhibition_risk_summary.list","text":"","code":"# S3 method for class 'list' cyp_inhibition_risk_summary(perp, ...)"},{"path":"/reference/cyp_inhibition_risk_summary.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary statement for CYP inhibition for a list of perpetrators — cyp_inhibition_risk_summary.list","text":"perp Perpetrator object. ... parameters.","code":""},{"path":"/reference/cyp_inhibition_risk_summary.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary statement for CYP inhibition for a list of perpetrators — cyp_inhibition_risk_summary.list","text":"Markdown-formatted text output.","code":""},{"path":"/reference/cyp_inhibition_risk_summary.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary statement for CYP inhibition for a precipitant compound — cyp_inhibition_risk_summary.perpetrator","title":"Summary statement for CYP inhibition for a precipitant compound — cyp_inhibition_risk_summary.perpetrator","text":"Summary statement CYP inhibition precipitant compound","code":""},{"path":"/reference/cyp_inhibition_risk_summary.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary statement for CYP inhibition for a precipitant compound — cyp_inhibition_risk_summary.perpetrator","text":"","code":"# S3 method for class 'perpetrator' cyp_inhibition_risk_summary(perp, cyp_inh)"},{"path":"/reference/cyp_inhibition_risk_summary.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary statement for CYP inhibition for a precipitant compound — cyp_inhibition_risk_summary.perpetrator","text":"perp perpetrator object. cyp_inh CYP inhibition data data frame. following fields expected: 'name' name perpetrator compound. 'cyp' CYP enzyme (upper case) character. 'ki' \\(K_i\\) \\(\\mu M\\) numeric. 'source' Optional source information character.","code":""},{"path":"/reference/cyp_inhibition_risk_summary.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary statement for CYP inhibition for a precipitant compound — cyp_inhibition_risk_summary.perpetrator","text":"Markdown-formatted text output.","code":""},{"path":"/reference/cyp_reference_substrates.html","id":null,"dir":"Reference","previous_headings":"","what":"CYP reference substrate data — cyp_reference_substrates","title":"CYP reference substrate data — cyp_reference_substrates","text":"CYP reference substrates commonly used mechanistic static assessment CYP DDI potential drugs.","code":""},{"path":"/reference/cyp_reference_substrates.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"CYP reference substrate data — cyp_reference_substrates","text":"","code":"cyp_reference_substrates"},{"path":"/reference/cyp_reference_substrates.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"CYP reference substrate data — cyp_reference_substrates","text":"object class tbl_df (inherits tbl, data.frame) 6 rows 5 columns.","code":""},{"path":"/reference/cyp_reference_substrates.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"CYP reference substrate data — cyp_reference_substrates","text":"FDA EMA guidelines.","code":""},{"path":"/reference/cyp_reference_substrates.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"CYP reference substrate data — cyp_reference_substrates","text":"CYP reference substrates currently implemented include:","code":"cyp     , substrate   , fgut , fm   , fmcyp CYP1A2  , tizanidine  , 1    , 0.95 , 0.98 CYP2C8  , repaglinide , 1    , 1    , 0.61 CYP2C9  , S-warfarin  , 1    , 1    , 0.91 CYP2C19 , omeprazole  , 1    , 1    , 0.87 CYP3A4  , midazolam   , 0.57 , 0.96 , 1"},{"path":[]},{"path":"/reference/cyp_tdi_risk_summary.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary statement for CYP TDI — cyp_tdi_risk_summary","title":"Summary statement for CYP TDI — cyp_tdi_risk_summary","text":"Summary statement CYP TDI","code":""},{"path":"/reference/cyp_tdi_risk_summary.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary statement for CYP TDI — cyp_tdi_risk_summary","text":"","code":"cyp_tdi_risk_summary(perp, cyp_tdi, cyp_kdeg = cyp_turnover)"},{"path":"/reference/cyp_tdi_risk_summary.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary statement for CYP TDI — cyp_tdi_risk_summary","text":"perp perpetrator object. cyp_tdi CYP TDI data data frame. following fields expected: 'name' perpetrator compound name character. 'cyp' CYP enzyme character. 'ki' \\(K_I\\) \\(\\mu M\\) numeric. 'kinact' \\(k_{inact}\\) 1/h numeric. 'source' Optional source information character, cyp_kdeg CYP turnover data data frame. Defaults built-reference data, cyp_turnover.","code":""},{"path":"/reference/cyp_tdi_risk_summary.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary statement for CYP TDI — cyp_tdi_risk_summary","text":"Markdown-formatted text output.","code":""},{"path":"/reference/cyp_tdi_risk_summary.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Summary statement for CYP TDI — cyp_tdi_risk_summary","text":"","code":"cyp_tdi_risk_summary(examplinib_parent, examplinib_cyp_tdi_data) #> [1] \"* examplinib has a clinical risk for time-dependent inhibition of CYP3A4\" cyp_tdi_risk_summary(examplinib_compounds, examplinib_cyp_tdi_data) #> [1] \"* examplinib has a clinical risk for time-dependent inhibition of CYP3A4\""},{"path":"/reference/cyp_tdi_risk_summary.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary statement for CYP TDI for a list of compounds — cyp_tdi_risk_summary.list","title":"Summary statement for CYP TDI for a list of compounds — cyp_tdi_risk_summary.list","text":"Summary statement CYP TDI list compounds","code":""},{"path":"/reference/cyp_tdi_risk_summary.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary statement for CYP TDI for a list of compounds — cyp_tdi_risk_summary.list","text":"","code":"# S3 method for class 'list' cyp_tdi_risk_summary(perp, ...)"},{"path":"/reference/cyp_tdi_risk_summary.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary statement for CYP TDI for a list of compounds — cyp_tdi_risk_summary.list","text":"perp list perpetrator objects. ... parameters.","code":""},{"path":"/reference/cyp_tdi_risk_summary.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary statement for CYP TDI for a list of compounds — cyp_tdi_risk_summary.list","text":"Markdown-formatted text output.","code":""},{"path":"/reference/cyp_tdi_risk_summary.list.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Summary statement for CYP TDI for a list of compounds — cyp_tdi_risk_summary.list","text":"","code":"cyp_tdi_risk_summary(examplinib_compounds, examplinib_cyp_tdi_data) #> [1] \"* examplinib has a clinical risk for time-dependent inhibition of CYP3A4\""},{"path":"/reference/cyp_tdi_risk_summary.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary statement for CYP TDI for a precipitant compound — cyp_tdi_risk_summary.perpetrator","title":"Summary statement for CYP TDI for a precipitant compound — cyp_tdi_risk_summary.perpetrator","text":"Summary statement CYP TDI precipitant compound","code":""},{"path":"/reference/cyp_tdi_risk_summary.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary statement for CYP TDI for a precipitant compound — cyp_tdi_risk_summary.perpetrator","text":"","code":"# S3 method for class 'perpetrator' cyp_tdi_risk_summary(perp, cyp_tdi, cyp_kdeg = cyp_turnover)"},{"path":"/reference/cyp_tdi_risk_summary.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary statement for CYP TDI for a precipitant compound — cyp_tdi_risk_summary.perpetrator","text":"perp perpetrator object. cyp_tdi CYP TDI data data frame. following fields expected: 'name' perpetrator compound name character. 'cyp' CYP enzyme character. 'ki' \\(K_I\\) \\(\\mu M\\) numeric. 'kinact' \\(k_{inact}\\) 1/h numeric. 'source' Optional source information character, cyp_kdeg CYP turnover data data frame. Defaults built-reference data, cyp_turnover.","code":""},{"path":"/reference/cyp_tdi_risk_summary.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary statement for CYP TDI for a precipitant compound — cyp_tdi_risk_summary.perpetrator","text":"Markdown-formatted text output.","code":""},{"path":"/reference/cyp_turnover.html","id":null,"dir":"Reference","previous_headings":"","what":"CYP turnover rate constants — cyp_turnover","title":"CYP turnover rate constants — cyp_turnover","text":"Mean degradation constants 1/h hepatic intestinal CYP enzymes.","code":""},{"path":"/reference/cyp_turnover.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"CYP turnover rate constants — cyp_turnover","text":"","code":"cyp_turnover"},{"path":"/reference/cyp_turnover.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"CYP turnover rate constants — cyp_turnover","text":"data frame 3 columns","code":""},{"path":"/reference/cyp_turnover.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"CYP turnover rate constants — cyp_turnover","text":"data set taken various literature sources","code":""},{"path":"/reference/cyp_turnover.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"CYP turnover rate constants — cyp_turnover","text":"","code":"cyp kdeg_hepatic kdeg_intestinal  CYP1A1       0.0183              NA  CYP1A2       0.0183              NA  CYP2A6       0.0267              NA  CYP2B6       0.0217              NA  CYP2C8       0.0301              NA  CYP2C9       0.0067            0.03 CYP2C18       0.0267              NA CYP2C19       0.0267            0.03  CYP2D6       0.0099            0.03  CYP2E1       0.0176              NA  CYP2J2       0.0194            0.03  CYP3A4       0.0193            0.03  CYP3A5       0.0193            0.03  CYP3A7       0.0193              NA"},{"path":[]},{"path":"/reference/ddi_report_template.html","id":null,"dir":"Reference","previous_headings":"","what":"Open report template — ddi_report_template","title":"Open report template — ddi_report_template","text":"Open report template","code":""},{"path":"/reference/ddi_report_template.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Open report template — ddi_report_template","text":"","code":"ddi_report_template()"},{"path":"/reference/ddi_report_template.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Open report template — ddi_report_template","text":"Nothing.","code":""},{"path":[]},{"path":"/reference/ddi_risk_summary.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Overall DDI risk summary text block — ddi_risk_summary","text":"","code":"ddi_risk_summary(   perp,   cyp_inh = NULL,   cyp_tdi = NULL,   cyp_ind = NULL,   ugt_inh = NULL,   transporter_inh = NULL,   d = 1,   include_induction = TRUE,   substr = cyp_reference_substrates,   cyp_kdeg = cyp_turnover )"},{"path":"/reference/ddi_risk_summary.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Overall DDI risk summary text block — ddi_risk_summary","text":"perp perpetrator object. cyp_inh CYP inhibition data data frame. following fields expected: 'name' name perpetrator compound. 'cyp' CYP enzyme (upper case) character. 'ki' \\(K_i\\) \\(\\mu M\\) numeric. 'source' Optional source information character. cyp_tdi CYP TDI data data frame. following fields expected: 'name' perpetrator compound name character. 'cyp' CYP enzyme character. 'ki' \\(K_I\\) \\(\\mu M\\) numeric. 'kinact' \\(k_{inact}\\) 1/h numeric. 'source' Optional source information character, cyp_ind CYP induction data data frame. following fields expected: 'name' name perpetrator compound character. 'cyp' CYP enzyme (upper case) character. 'emax' \\(E_{max}\\), .e., maximum induction effect determined vitro numeric. 'ec50' \\(EC_{50}\\) \\(\\mu M\\) numeric. 'maxc' maximal concentration \\(\\mu M\\) tested vitro assay numeric. 'source' Optional source information character. ugt_inh UGT inhibition data data frame, following fields expected: 'name' name perpetrator compound. 'ugt' UGT enzyme (upper case) character. 'ic50' \\(IC_{50}\\) \\(\\mu M\\) numeric. 'source' Optional source information character. transporter_inh Transporter inhibition data data frame. following fields expected: 'name' perpetrator compound name. 'cyp' UGT enzyme (upper case) character. 'ic50' \\(IC_{50}\\) inhibition μM. 'source' Optional source information character. d Scaling factor, defaults 1. include_induction Switch define whether induction effects included calculation (C-terms per FDA guideline) substr CYP probe substrates used data frame, defaults cyp_reference_substrates. data frame expected following fields: 'cyp' CYP enzyme (upper case) character. 'substrate' substrate name character. 'fgut' fraction drug escaping gut metabolism. 'fm' fraction drug undergoes hepatic metabolism. 'fmcyp' fraction metabolized respective CYP enzyme. cyp_kdeg CYP turnover data data frame. Defaults built-reference data, cyp_turnover.","code":""},{"path":"/reference/ddi_risk_summary.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Overall DDI risk summary text block — ddi_risk_summary","text":"Markdown-formatted text output.","code":""},{"path":"/reference/ddi_risk_summary.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Overall DDI risk summary text block — ddi_risk_summary","text":"","code":"ddi_risk_summary(examplinib_compounds, examplinib_cyp_inhibition_data,   examplinib_cyp_tdi_data, examplinib_cyp_induction_data,   examplinib_ugt_inhibition_data, examplinib_transporter_inhibition_data) #> [1] \"* examplinib has a clinical risk for direct inhibition of CYP2C9 and CYP2C19 (basic modeling)\\n* examplinib has a clinical risk for time-dependent inhibition of CYP3A4\\n* examplinib has a clinical risk for induction of CYP3A4 (fold-change method)\\n* examplinib has a clinical risk for induction of CYP3A4 (basic kinetic method)\\n* M1 has a clinical risk for induction of CYP2B6 and CYP3A4 (fold-change method)\\n* M1 has a clinical risk for induction of CYP2B6 and CYP3A4 (basic kinetic method)\\n* based on mechanistic-static modeling (S-warfarin and omeprazole), examplinib has a clinical risk for inhibition of CYP2C9 and CYP2C19\\n* based on mechanistic-static modeling (midazolam), examplinib has a clinical risk for induction of CYP3A4\\n* examplinib has a clinical risk for inhibition of UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A9, UGT2B7, UGT2B15 and UGT2B17\\n* M1 has a clinical risk for inhibition of UGT1A1 and UGT2B17\\n* examplinib has a clinical risk for inhibition of P-gp (intestinal), P-gp (hepatic), BCRP (intestinal), BCRP (hepatic), MATE1 and MATE2k\" ddi_risk_summary(examplinib_parent, examplinib_cyp_inhibition_data) #> [1] \"* examplinib has a clinical risk for direct inhibition of CYP2C9 and CYP2C19 (basic modeling)\\n* based on mechanistic-static modeling (S-warfarin and omeprazole), examplinib has a clinical risk for inhibition of CYP2C9 and CYP2C19\""},{"path":"/reference/ddir-package.html","id":null,"dir":"Reference","previous_headings":"","what":"ddir: Assess the Clinical Drug-Drug Interaction Risk for Drug Compounds — ddir-package","title":"ddir: Assess the Clinical Drug-Drug Interaction Risk for Drug Compounds — ddir-package","text":"goal ddir facilitate analysis drug-drug interaction risk drugs per relevant FDA EMA guidelines.","code":""},{"path":"/reference/dose.html","id":null,"dir":"Reference","previous_headings":"","what":"Oral dose — dose","title":"Oral dose — dose","text":"Oral dose","code":""},{"path":"/reference/dose.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Oral dose — dose","text":"","code":"dose(obj)"},{"path":"/reference/dose.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Oral dose — dose","text":"obj perpetrator object list thereof.","code":""},{"path":"/reference/dose.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Oral dose — dose","text":"Oral dose(s) character","code":""},{"path":"/reference/dose.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Oral dose — dose","text":"","code":"dose(examplinib_parent) #> [1] \"450 mg\" dose(examplinib_metabolite) #> NULL dose(examplinib_compounds) #> [1] \"450 mg\""},{"path":"/reference/dose.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Oral doses of compound list — dose.list","title":"Oral doses of compound list — dose.list","text":"Oral doses compound list","code":""},{"path":"/reference/dose.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Oral doses of compound list — dose.list","text":"","code":"# S3 method for class 'list' dose(obj)"},{"path":"/reference/dose.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Oral doses of compound list — dose.list","text":"obj List perpetrator objects.","code":""},{"path":"/reference/dose.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Oral doses of compound list — dose.list","text":"Text output.","code":""},{"path":"/reference/dose.list.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Oral doses of compound list — dose.list","text":"","code":"dose(examplinib_compounds) #> [1] \"450 mg\""},{"path":"/reference/dose.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Oral dose of perpetrator — dose.perpetrator","title":"Oral dose of perpetrator — dose.perpetrator","text":"Oral dose perpetrator","code":""},{"path":"/reference/dose.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Oral dose of perpetrator — dose.perpetrator","text":"","code":"# S3 method for class 'perpetrator' dose(obj)"},{"path":"/reference/dose.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Oral dose of perpetrator — dose.perpetrator","text":"obj Perpetrator object.","code":""},{"path":"/reference/dose.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Oral dose of perpetrator — dose.perpetrator","text":"Dose character.","code":""},{"path":"/reference/dose.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Oral dose of perpetrator — dose.perpetrator","text":"","code":"dose(examplinib_parent) #> [1] \"450 mg\" dose(examplinib_metabolite) #> NULL"},{"path":"/reference/examplinib_compounds.html","id":null,"dir":"Reference","previous_headings":"","what":"Perpetrator compound data for examplinib and its metabolite — examplinib_compounds","title":"Perpetrator compound data for examplinib and its metabolite — examplinib_compounds","text":"list two: perpetrator objects: examplinib, fictional drug. M1, fictional metabolite examplinib.","code":""},{"path":"/reference/examplinib_compounds.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Perpetrator compound data for examplinib and its metabolite — examplinib_compounds","text":"","code":"examplinib_compounds"},{"path":"/reference/examplinib_compounds.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Perpetrator compound data for examplinib and its metabolite — examplinib_compounds","text":"object class list length 2.","code":""},{"path":"/reference/examplinib_compounds.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Perpetrator compound data for examplinib and its metabolite — examplinib_compounds","text":"Fictional data, made demo purposes.","code":""},{"path":"/reference/examplinib_compounds_single_string.html","id":null,"dir":"Reference","previous_headings":"","what":"Examplinib compound data for parent only as string — examplinib_compounds_single_string","title":"Examplinib compound data for parent only as string — examplinib_compounds_single_string","text":"character string containing data one perpetrator object: examplinib, fictional drug.","code":""},{"path":"/reference/examplinib_compounds_single_string.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Examplinib compound data for parent only as string — examplinib_compounds_single_string","text":"","code":"examplinib_compounds_single_string"},{"path":"/reference/examplinib_compounds_single_string.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Examplinib compound data for parent only as string — examplinib_compounds_single_string","text":"object class character length 1.","code":""},{"path":"/reference/examplinib_compounds_single_string.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Examplinib compound data for parent only as string — examplinib_compounds_single_string","text":"Fictional data, made demo purposes.","code":""},{"path":[]},{"path":"/reference/examplinib_compounds_string.html","id":null,"dir":"Reference","previous_headings":"","what":"Examplinib compound data as string — examplinib_compounds_string","title":"Examplinib compound data as string — examplinib_compounds_string","text":"character string containing data two perpetrator objects: examplinib, fictional drug. M1, fictional metabolite examplinib.","code":""},{"path":"/reference/examplinib_compounds_string.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Examplinib compound data as string — examplinib_compounds_string","text":"","code":"examplinib_compounds_string"},{"path":"/reference/examplinib_compounds_string.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Examplinib compound data as string — examplinib_compounds_string","text":"object class character length 1.","code":""},{"path":"/reference/examplinib_compounds_string.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Examplinib compound data as string — examplinib_compounds_string","text":"Fictional data, made demo purposes.","code":""},{"path":[]},{"path":"/reference/examplinib_cyp_induction_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Examplinib CYP induction data — examplinib_cyp_induction_data","title":"Examplinib CYP induction data — examplinib_cyp_induction_data","text":"Examplinib CYP induction data","code":""},{"path":"/reference/examplinib_cyp_induction_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Examplinib CYP induction data — examplinib_cyp_induction_data","text":"","code":"examplinib_cyp_induction_data"},{"path":"/reference/examplinib_cyp_induction_data.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Examplinib CYP induction data — examplinib_cyp_induction_data","text":"object class data.frame 14 rows 6 columns.","code":""},{"path":"/reference/examplinib_cyp_induction_data.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Examplinib CYP induction data — examplinib_cyp_induction_data","text":"Fictional data, made demo purposes.","code":""},{"path":"/reference/examplinib_cyp_induction_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Examplinib CYP induction data — examplinib_cyp_induction_data","text":"","code":"name     cyp  emax ec50 maxc    source examplinib  CYP1A2  1.00   NA    5 study 007 examplinib  CYP2B6  1.00   NA    5 study 007 examplinib  CYP2C8    NA   NA   NA examplinib  CYP2C9    NA   NA   NA examplinib CYP2C19    NA   NA   NA examplinib  CYP2D6    NA   NA   NA examplinib  CYP3A4  7.35 1.64    3 study 007         M1  CYP1A2  1.00   NA    5 study 007         M1  CYP2B6  6.98 1.86    5 study 007         M1  CYP2C8    NA   NA   NA         M1  CYP2C9    NA   NA   NA         M1 CYP2C19    NA   NA   NA         M1  CYP2D6    NA   NA   NA         M1  CYP3A4 22.70 1.10    5 study 007"},{"path":"/reference/examplinib_cyp_induction_string.html","id":null,"dir":"Reference","previous_headings":"","what":"Examplinib CYP induction data as string — examplinib_cyp_induction_string","title":"Examplinib CYP induction data as string — examplinib_cyp_induction_string","text":"character string containing CYP induction data examplinib M1.","code":""},{"path":"/reference/examplinib_cyp_induction_string.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Examplinib CYP induction data as string — examplinib_cyp_induction_string","text":"","code":"examplinib_cyp_induction_string"},{"path":"/reference/examplinib_cyp_induction_string.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Examplinib CYP induction data as string — examplinib_cyp_induction_string","text":"object class character length 1.","code":""},{"path":"/reference/examplinib_cyp_induction_string.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Examplinib CYP induction data as string — examplinib_cyp_induction_string","text":"Fictional data demo purposes.","code":""},{"path":[]},{"path":"/reference/examplinib_cyp_inhibition_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Examplinib CYP inhibition data — examplinib_cyp_inhibition_data","title":"Examplinib CYP inhibition data — examplinib_cyp_inhibition_data","text":"data frame typical input following functions: basic_cyp_inhibition_risk() basic_cyp_inhibition_risk_table mech_stat_cyp_risk() mech_stat_cyp_risk_table()","code":""},{"path":"/reference/examplinib_cyp_inhibition_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Examplinib CYP inhibition data — examplinib_cyp_inhibition_data","text":"","code":"examplinib_cyp_inhibition_data"},{"path":[]},{"path":"/reference/examplinib_cyp_inhibition_data.html","id":"examplinib-cyp-inhibition-data","dir":"Reference","previous_headings":"","what":"examplinib_cyp_inhibition_data","title":"Examplinib CYP inhibition data — examplinib_cyp_inhibition_data","text":"data frame columns name, param, value source, : name name compound data recorded param contains respective CYP enzyme names. value contains Ki values respective CYP enzyme source provides information source respective value, often name DMPK study. entry optional.","code":""},{"path":"/reference/examplinib_cyp_inhibition_data.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Examplinib CYP inhibition data — examplinib_cyp_inhibition_data","text":"Fictional data, made demo purposes.","code":""},{"path":"/reference/examplinib_cyp_inhibition_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Examplinib CYP inhibition data — examplinib_cyp_inhibition_data","text":"CYP inhibition data can contain ki data multiple compounds.","code":"name   param      value    source         M1    name         M1         M1  CYP2C9        4.4 study 002 examplinib    name examplinib examplinib  CYP1A2         NA examplinib  CYP2B6         NA examplinib  CYP2C8         11 study 001 examplinib  CYP2C9       13.5 study 001 examplinib CYP2C19         15 study 001 examplinib  CYP2D6         NA examplinib  CYP3A4       12.5 study 001"},{"path":"/reference/examplinib_cyp_inhibition_string.html","id":null,"dir":"Reference","previous_headings":"","what":"Examplinib CYP inhibitor data as string — examplinib_cyp_inhibition_string","title":"Examplinib CYP inhibitor data as string — examplinib_cyp_inhibition_string","text":"character string containing CYP inhibition data examplinib M1.","code":""},{"path":"/reference/examplinib_cyp_inhibition_string.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Examplinib CYP inhibitor data as string — examplinib_cyp_inhibition_string","text":"","code":"examplinib_cyp_inhibition_string"},{"path":"/reference/examplinib_cyp_inhibition_string.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Examplinib CYP inhibitor data as string — examplinib_cyp_inhibition_string","text":"object class character length 1.","code":""},{"path":"/reference/examplinib_cyp_inhibition_string.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Examplinib CYP inhibitor data as string — examplinib_cyp_inhibition_string","text":"Fictional data demo purposes.","code":""},{"path":[]},{"path":"/reference/examplinib_cyp_tdi_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Examplinib CYP TDI data — examplinib_cyp_tdi_data","title":"Examplinib CYP TDI data — examplinib_cyp_tdi_data","text":"Examplinib CYP TDI data","code":""},{"path":"/reference/examplinib_cyp_tdi_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Examplinib CYP TDI data — examplinib_cyp_tdi_data","text":"","code":"examplinib_cyp_tdi_data"},{"path":"/reference/examplinib_cyp_tdi_data.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Examplinib CYP TDI data — examplinib_cyp_tdi_data","text":"object class data.frame 1 rows 5 columns.","code":""},{"path":"/reference/examplinib_cyp_tdi_data.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Examplinib CYP TDI data — examplinib_cyp_tdi_data","text":"Fictional data, made demo purposes.","code":""},{"path":"/reference/examplinib_cyp_tdi_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Examplinib CYP TDI data — examplinib_cyp_tdi_data","text":"","code":"name    cyp   ki kinact    source examplinib CYP3A4 30.7   0.04 study 001"},{"path":"/reference/examplinib_cyp_tdi_string.html","id":null,"dir":"Reference","previous_headings":"","what":"Examplinib CYP TDI data as string — examplinib_cyp_tdi_string","title":"Examplinib CYP TDI data as string — examplinib_cyp_tdi_string","text":"character string containing CYP TDI data examplinib.","code":""},{"path":"/reference/examplinib_cyp_tdi_string.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Examplinib CYP TDI data as string — examplinib_cyp_tdi_string","text":"","code":"examplinib_cyp_tdi_string"},{"path":"/reference/examplinib_cyp_tdi_string.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Examplinib CYP TDI data as string — examplinib_cyp_tdi_string","text":"object class character length 1.","code":""},{"path":"/reference/examplinib_cyp_tdi_string.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Examplinib CYP TDI data as string — examplinib_cyp_tdi_string","text":"Fictional data demo purposes.","code":""},{"path":[]},{"path":"/reference/examplinib_metabolite.html","id":null,"dir":"Reference","previous_headings":"","what":"Perpetrator compound data for examplinib — examplinib_metabolite","title":"Perpetrator compound data for examplinib — examplinib_metabolite","text":"Perpetrator compound data examplinib","code":""},{"path":"/reference/examplinib_metabolite.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Perpetrator compound data for examplinib — examplinib_metabolite","text":"","code":"examplinib_metabolite"},{"path":"/reference/examplinib_metabolite.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Perpetrator compound data for examplinib — examplinib_metabolite","text":"object class perpetrator (inherits data.frame) 12 rows 3 columns.","code":""},{"path":"/reference/examplinib_metabolite.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Perpetrator compound data for examplinib — examplinib_metabolite","text":"Fictional data, made demo purposes.","code":""},{"path":"/reference/examplinib_metabolite.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Perpetrator compound data for examplinib — examplinib_metabolite","text":"","code":"param  value    source name             name     M1 oral             oral  FALSE mw                 mw 506.56 dose             dose     NA imaxss         imaxss   1038 study 001 fu                 fu  0.012 study 002 fumic           fumic      1   default rb                 rb      1 study 002 fa                 fa     NA fg                 fg     NA ka                 ka     NA solubility solubility    Inf   default"},{"path":"/reference/examplinib_parent.html","id":null,"dir":"Reference","previous_headings":"","what":"Perpetrator compound data for examplinib — examplinib_parent","title":"Perpetrator compound data for examplinib — examplinib_parent","text":"Perpetrator compound data examplinib","code":""},{"path":"/reference/examplinib_parent.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Perpetrator compound data for examplinib — examplinib_parent","text":"","code":"examplinib_parent"},{"path":"/reference/examplinib_parent.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Perpetrator compound data for examplinib — examplinib_parent","text":"object class perpetrator (inherits data.frame) 12 rows 3 columns.","code":""},{"path":"/reference/examplinib_parent.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Perpetrator compound data for examplinib — examplinib_parent","text":"Fictional data, made demo purposes.","code":""},{"path":"/reference/examplinib_parent.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Perpetrator compound data for examplinib — examplinib_parent","text":"","code":"param      value        source name             name examplinib oral             oral       TRUE mw                 mw      492.6 dose             dose        450 clinical dose imaxss         imaxss       3530     study 001 fu                 fu      0.023     study 002 fumic           fumic          1       default rb                 rb          1     study 003 fa                 fa       0.81     study 003 fg                 fg          1       default ka                 ka    0.00267       unknown solubility solubility        Inf       default"},{"path":"/reference/examplinib_transporter_inhibition_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Examplinib transporter inhibition data — examplinib_transporter_inhibition_data","title":"Examplinib transporter inhibition data — examplinib_transporter_inhibition_data","text":"Examplinib transporter inhibition data","code":""},{"path":"/reference/examplinib_transporter_inhibition_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Examplinib transporter inhibition data — examplinib_transporter_inhibition_data","text":"","code":"examplinib_transporter_inhibition_data"},{"path":"/reference/examplinib_transporter_inhibition_data.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Examplinib transporter inhibition data — examplinib_transporter_inhibition_data","text":"object class data.frame 11 rows 4 columns.","code":""},{"path":"/reference/examplinib_transporter_inhibition_data.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Examplinib transporter inhibition data — examplinib_transporter_inhibition_data","text":"Fictional data, made demo purposes.","code":""},{"path":"/reference/examplinib_transporter_inhibition_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Examplinib transporter inhibition data — examplinib_transporter_inhibition_data","text":"","code":"name   param      value    source examplinib    name examplinib examplinib     Pgp       0.41 study 005 examplinib    BCRP        1.9 study 005 examplinib    OCT1        2.3 study 006 examplinib OATP1B1        177 study 006 examplinib OATP1B3         35 study 006 examplinib    OAT1        271 examplinib    OAT3        300 examplinib    BSEP       12.8 examplinib    OCT2         67 study 006 examplinib   MATE1        3.6 study 006 examplinib  MATE2k        1.1 study 006"},{"path":"/reference/examplinib_transporter_inhibition_string.html","id":null,"dir":"Reference","previous_headings":"","what":"Examplinib transporter inhibition data as string — examplinib_transporter_inhibition_string","title":"Examplinib transporter inhibition data as string — examplinib_transporter_inhibition_string","text":"character string containing transporter inhibition data examplinib M1.","code":""},{"path":"/reference/examplinib_transporter_inhibition_string.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Examplinib transporter inhibition data as string — examplinib_transporter_inhibition_string","text":"","code":"examplinib_transporter_inhibition_string"},{"path":"/reference/examplinib_transporter_inhibition_string.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Examplinib transporter inhibition data as string — examplinib_transporter_inhibition_string","text":"object class character length 1.","code":""},{"path":"/reference/examplinib_transporter_inhibition_string.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Examplinib transporter inhibition data as string — examplinib_transporter_inhibition_string","text":"Fictional data demo purposes.","code":""},{"path":[]},{"path":"/reference/examplinib_ugt_inhibition_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Examplinib UGT inhibition data — examplinib_ugt_inhibition_data","title":"Examplinib UGT inhibition data — examplinib_ugt_inhibition_data","text":"Examplinib UGT inhibition data","code":""},{"path":"/reference/examplinib_ugt_inhibition_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Examplinib UGT inhibition data — examplinib_ugt_inhibition_data","text":"","code":"examplinib_ugt_inhibition_data"},{"path":"/reference/examplinib_ugt_inhibition_data.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Examplinib UGT inhibition data — examplinib_ugt_inhibition_data","text":"data frame columns 'name', 'param', 'value' 'source'","code":""},{"path":"/reference/examplinib_ugt_inhibition_data.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Examplinib UGT inhibition data — examplinib_ugt_inhibition_data","text":"Fictional data, made demo purposes.","code":""},{"path":"/reference/examplinib_ugt_inhibition_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Examplinib UGT inhibition data — examplinib_ugt_inhibition_data","text":"","code":"name   param      value    source         M1    name         M1         M1  UGT1A1        1.1 study 009         M1  UGT1A3        5.8 study 009         M1  UGT1A4        6.2 study 009         M1  UGT1A6         15 study 009         M1  UGT1A9        3.6 study 009         M1  UGT2B7         15 study 009         M1 UGT2B15        9.6 study 009         M1 UGT2B17        2.2 study 009 examplinib    name examplinib examplinib  UGT1A1         15 study 009 examplinib  UGT1A3         15 study 009 examplinib  UGT1A4         15 study 009 examplinib  UGT1A6         15 study 009 examplinib  UGT1A9        3.8 study 009 examplinib  UGT2B7         15 study 009 examplinib UGT2B15         15 study 009 examplinib UGT2B17        6.1 study 009"},{"path":"/reference/examplinib_ugt_inhibition_string.html","id":null,"dir":"Reference","previous_headings":"","what":"Examplinib UGT inhibition data as string — examplinib_ugt_inhibition_string","title":"Examplinib UGT inhibition data as string — examplinib_ugt_inhibition_string","text":"character string containing UGT inhibition data examplinib M1.","code":""},{"path":"/reference/examplinib_ugt_inhibition_string.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Examplinib UGT inhibition data as string — examplinib_ugt_inhibition_string","text":"","code":"examplinib_ugt_inhibition_string"},{"path":"/reference/examplinib_ugt_inhibition_string.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Examplinib UGT inhibition data as string — examplinib_ugt_inhibition_string","text":"object class character length 1.","code":""},{"path":"/reference/examplinib_ugt_inhibition_string.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Examplinib UGT inhibition data as string — examplinib_ugt_inhibition_string","text":"Fictional data demo purposes.","code":""},{"path":[]},{"path":"/reference/hepatic_cyp_turnover.html","id":null,"dir":"Reference","previous_headings":"","what":"Hepatic CYP turnover data based on various publications — hepatic_cyp_turnover","title":"Hepatic CYP turnover data based on various publications — hepatic_cyp_turnover","text":"Please use cyp_turnover instead.","code":""},{"path":"/reference/hepatic_cyp_turnover.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Hepatic CYP turnover data based on various publications — hepatic_cyp_turnover","text":"","code":"hepatic_cyp_turnover"},{"path":"/reference/hepatic_cyp_turnover.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Hepatic CYP turnover data based on various publications — hepatic_cyp_turnover","text":"data frame 6 columns: cyp: CYP enzymne method: experimental method used () mean_hl: mean CYP degradation half-life measured, in_vivo: Study conducted vivo reference: source publication (PMID DOI) kdeg: CYP degradation constant, .e., \\(log(2)/mean half-life\\).","code":""},{"path":"/reference/hepatic_cyp_turnover.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Hepatic CYP turnover data based on various publications — hepatic_cyp_turnover","text":"data set taken : Yang J, Liao M, Shou M, Jamei M, Yeo KR, Tucker GT, Rostami-Hodjegan . Cytochrome p450 turnover: regulation synthesis degradation, methods determining rates, implications prediction drug interactions. Curr Drug Metab. 2008 Jun;9(5):384-94. doi: 10.2174/138920008784746382. PMID: 18537575.","code":""},{"path":"/reference/hepatic_cyp_turnover.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Hepatic CYP turnover data based on various publications — hepatic_cyp_turnover","text":"following experimental methods used original publication: vitro method 1: Radio-labeling enzyme (‘pulse-chase’ method) vitro method 2: Degradation enzyme cultured hepatocytes liver slices vivo method 1: Recovery enzyme activity enzyme induction vivo method 2: Recovery enzyme activity mechanism-based inhibition (MBI) vivo method 3: Pharmacokinetic modeling auto-induction first lines data frame:","code":"cyp            method mean_hl in_vivo                       reference   kdeg CYP1A2 In vitro Method 1      51   FALSE                   PMID: 2136526 0.0136 CYP1A2 In vitro Method 2      43   FALSE   DOI: 10.1007/3-540-29804-5_25 0.0161 CYP1A2 In vitro Method 2      36   FALSE                  PMID: 10997941 0.0193 CYP1A2  In vivo Method 1      39    TRUE DOI: 10.1016/j.clpt.2004.04.003 0.0178 CYP1A2  In vivo Method 3     105    TRUE    DOI: 10.1038/sj.clpt.6100431 0.0066 CYP2A6 In vitro Method 2     226   FALSE                  PMID: 10997941 0.0031"},{"path":"/reference/is_igut_solubility_limited.html","id":null,"dir":"Reference","previous_headings":"","what":"Test if Igut of a perpetrator is limited by its solubility — is_igut_solubility_limited","title":"Test if Igut of a perpetrator is limited by its solubility — is_igut_solubility_limited","text":"function tests whether solubility perpetrator compound limiting intestinal concentration.","code":""},{"path":"/reference/is_igut_solubility_limited.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Test if Igut of a perpetrator is limited by its solubility — is_igut_solubility_limited","text":"","code":"is_igut_solubility_limited(obj)"},{"path":"/reference/is_igut_solubility_limited.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Test if Igut of a perpetrator is limited by its solubility — is_igut_solubility_limited","text":"obj perpetrator object.","code":""},{"path":"/reference/is_igut_solubility_limited.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Test if Igut of a perpetrator is limited by its solubility — is_igut_solubility_limited","text":"Boolean value.","code":""},{"path":"/reference/is_igut_solubility_limited.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Test if Igut of a perpetrator is limited by its solubility — is_igut_solubility_limited","text":"'solubility' field Inf (default), compound solubility larger \\(I_{gut}\\), function returns FALSE. solubility lower theoretical \\(I_{gut}\\), .e., lower dose dissolved 250 ml, function returns TRUE. Note solubility expected mg/l.","code":""},{"path":[]},{"path":"/reference/is_igut_solubility_limited.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Test if Igut of a perpetrator is limited by its solubility — is_igut_solubility_limited","text":"","code":"is_igut_solubility_limited(examplinib_parent) #> [1] FALSE"},{"path":"/reference/is_oral.html","id":null,"dir":"Reference","previous_headings":"","what":"Test whether perpetrator is subject to first-pass elimination — is_oral","title":"Test whether perpetrator is subject to first-pass elimination — is_oral","text":"Test whether perpetrator subject first-pass elimination","code":""},{"path":"/reference/is_oral.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Test whether perpetrator is subject to first-pass elimination — is_oral","text":"","code":"is_oral(obj)"},{"path":"/reference/is_oral.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Test whether perpetrator is subject to first-pass elimination — is_oral","text":"obj perpetrator object.","code":""},{"path":"/reference/is_oral.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Test whether perpetrator is subject to first-pass elimination — is_oral","text":"Logical","code":""},{"path":"/reference/is_oral.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Test whether perpetrator is subject to first-pass elimination — is_oral","text":"","code":"is_oral(examplinib_parent) #> [1] TRUE is_oral(examplinib_metabolite) #> [1] FALSE"},{"path":"/reference/key_concentrations.html","id":null,"dir":"Reference","previous_headings":"","what":"Key perpetrator concentrations — key_concentrations","title":"Key perpetrator concentrations — key_concentrations","text":"function calculates relevant perpetrator concentrations \\(\\mu M\\) (default) ng/ml DDI perpetrator compound.","code":""},{"path":"/reference/key_concentrations.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Key perpetrator concentrations — key_concentrations","text":"","code":"key_concentrations(obj, qh = 1.616, qent = 18/60, molar = TRUE)"},{"path":"/reference/key_concentrations.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Key perpetrator concentrations — key_concentrations","text":"obj perpetrator object. qh Hepatic blood flow l/min, defaults 1.616 l/min. qent Enteric blood flow l/min, defaults 0.3 l/min = 18 l/h. molar Switch select output molar concentrations.","code":""},{"path":"/reference/key_concentrations.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Key perpetrator concentrations — key_concentrations","text":"Key perpetrator concentrations uM (default) ng/ml named vector.","code":""},{"path":[]},{"path":"/reference/key_concentrations.html","id":"gut-concentration","dir":"Reference","previous_headings":"","what":"Gut concentration","title":"Key perpetrator concentrations — key_concentrations","text":"$$I_{gut} = \\frac{D} {250}$$ exceeds aqueous solubility drug, \\(I_{gut}\\) set solubility.","code":""},{"path":"/reference/key_concentrations.html","id":"unbound-systemic-concentration","dir":"Reference","previous_headings":"","what":"Unbound systemic concentration","title":"Key perpetrator concentrations — key_concentrations","text":"$$I_{max,ss,u}=I_{max,ss} * f_u$$","code":""},{"path":"/reference/key_concentrations.html","id":"unbound-hepatic-inlet-concentration","dir":"Reference","previous_headings":"","what":"Unbound hepatic inlet concentration","title":"Key perpetrator concentrations — key_concentrations","text":"orally administered (parent) compounds, hepatic inlet concentration systemic concentration plus portal term: $$portal\\ term = D*\\frac{F_a*F_g*k_a}{Q_h*R_B}*1000\\ ng/ml$$ \\(D\\) administered dose mg, \\(F_a\\) fraction absorbed oral administration, \\(F_g\\) fraction available gut metabolism, \\(k_a\\) absorption rate, \\(Q_h\\) hepatic blood flow \\(R_B\\) blood--plasma ratio. relevant hepatic inlet concentration (\\(I_{max,inlet,u}\\), also called \\(I_h\\) mechanistic static modeling equations) concentration sum maximal systemic plasma concentration portal contribution: $$I_{max,inlet,u}=(I_{max,ss} + portal\\ term) * f_u$$","code":""},{"path":"/reference/key_concentrations.html","id":"enteric-villous-concentration","dir":"Reference","previous_headings":"","what":"Enteric (villous) concentration","title":"Key perpetrator concentrations — key_concentrations","text":"orally administered (parent) compounds, villous concentration gut (\\(I_{enteric}\\), also called \\(I_g\\) mechanistic static modeling equations) calculated : $$I_{enteric,u} = D * \\frac{F_a*k_a}{Q_{ent}} *1000\\ ng/ml$$ \\(F_a\\) fraction absorbed oral administration, \\(k_a\\) absorption rate, \\(Q_{ent}\\) enteric villous blood flow \\(R_B\\) blood--plasma distribution ratio compound. Note per FDA guideline (refer FDA, 2020, Fig. 7, Rostami-Hodjegan Tucker, 2004) blood--plasma ratio plasma binding drug applicable.","code":""},{"path":[]},{"path":"/reference/key_concentrations.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Key perpetrator concentrations — key_concentrations","text":"","code":"key_concentrations(examplinib_parent) #>         igut      imaxssu   imaxinletu   imaxintest  #> 3654.0803898    0.1648193    0.1929384    6.5855664  key_concentrations(examplinib_parent, molar = FALSE) #>         igut      imaxssu   imaxinletu   imaxintest  #> 1.800000e+06 8.119000e+01 9.504145e+01 3.244050e+03  key_concentrations(examplinib_metabolite) #>       igut    imaxssu imaxinletu imaxintest  #> 0.00000000 0.02458939 0.02458939 0.02458939"},{"path":"/reference/kinetic_cyp_induction_risk.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk","text":"Basic kinetic CYP induction risk","code":""},{"path":"/reference/kinetic_cyp_induction_risk.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk","text":"","code":"kinetic_cyp_induction_risk(perp, cyp_ind, d = 1)"},{"path":"/reference/kinetic_cyp_induction_risk.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk","text":"perp perpetrator object list thereof. cyp_ind CYP induction data data frame. following fields expected: 'name' name perpetrator compound character. 'cyp' CYP enzyme (upper case) character. 'emax' \\(E_{max}\\), .e., maximum induction effect determined vitro numeric. 'ec50' \\(EC_{50}\\) \\(\\mu M\\) numeric. 'maxc' maximal concentration \\(\\mu M\\) tested vitro assay numeric. 'source' Optional source information character. d Scaling factor, defaults 1.","code":""},{"path":"/reference/kinetic_cyp_induction_risk.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk","text":"data frame.","code":""},{"path":"/reference/kinetic_cyp_induction_risk.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk","text":"Basic kinetic modeling CYP induction risk considers: $$R = \\frac {1}{1 + d * \\frac {E_{max}*10*C_{max,ss,u}}{EC_{50,u} + 10 * C_{max,ss,u}}}$$ \\(d\\) scaling factor standard value 1. different value can used warranted prior experience experimental conditions. \\(R \\le 0.8\\) suggest relevant vivo CYP induction potential.","code":""},{"path":"/reference/kinetic_cyp_induction_risk.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk","text":"","code":"kinetic_cyp_induction_risk(examplinib_parent, examplinib_cyp_induction_data) #>       cyp emax ec50 maxc    source         r risk #> 1  CYP1A2 1.00   NA    5 study 007        NA   NA #> 2  CYP2B6 1.00   NA    5 study 007        NA   NA #> 3  CYP2C8   NA   NA   NA                  NA   NA #> 4  CYP2C9   NA   NA   NA                  NA   NA #> 5 CYP2C19   NA   NA   NA                  NA   NA #> 6  CYP2D6   NA   NA   NA                  NA   NA #> 7  CYP3A4 7.35 1.64    3 study 007 0.2134856 TRUE"},{"path":"/reference/kinetic_cyp_induction_risk_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of the basic kinetic CYP induction risk — kinetic_cyp_induction_risk_table","title":"Table of the basic kinetic CYP induction risk — kinetic_cyp_induction_risk_table","text":"Table basic kinetic CYP induction risk","code":""},{"path":"/reference/kinetic_cyp_induction_risk_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of the basic kinetic CYP induction risk — kinetic_cyp_induction_risk_table","text":"","code":"kinetic_cyp_induction_risk_table(perp, cyp_ind, na.rm = F, show_dose = FALSE)"},{"path":"/reference/kinetic_cyp_induction_risk_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of the basic kinetic CYP induction risk — kinetic_cyp_induction_risk_table","text":"perp perpetrator object list thereof. cyp_ind CYP induction data data frame. following fields expected: 'name' name perpetrator compound character. 'cyp' CYP enzyme (upper case) character. 'emax' \\(E_{max}\\), .e., maximum induction effect determined vitro numeric. 'ec50' \\(EC_{50}\\) \\(\\mu M\\) numeric. 'maxc' maximal concentration \\(\\mu M\\) tested vitro assay numeric. 'source' Optional source information character. na.rm Switch define whether rows lacking \\(E_{max}\\) data removed output. Defaults FALSE. show_dose Show perpetrator dose table title, defaults FALSE.","code":""},{"path":"/reference/kinetic_cyp_induction_risk_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of the basic kinetic CYP induction risk — kinetic_cyp_induction_risk_table","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/kinetic_cyp_induction_risk_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of the basic kinetic CYP induction risk — kinetic_cyp_induction_risk_table","text":"","code":"kinetic_cyp_induction_risk_table(examplinib_parent,   examplinib_cyp_induction_data) #>  #>  #> Table: Risk for CYP induction by examplinib, basic kinetic model #>  #> |CYP     | $E_{max}$| $EC_{50}$ ($\\mu M$)|source    |$R$  |risk | #> |:-------|---------:|-------------------:|:---------|:----|:----| #> |CYP1A2  |      1.00|                  NA|study 007 |NA   |     | #> |CYP2B6  |      1.00|                  NA|study 007 |NA   |     | #> |CYP2C8  |        NA|                  NA|          |NA   |     | #> |CYP2C9  |        NA|                  NA|          |NA   |     | #> |CYP2C19 |        NA|                  NA|          |NA   |     | #> |CYP2D6  |        NA|                  NA|          |NA   |     | #> |CYP3A4  |      7.35|                1.64|study 007 |0.21 |Yes  | kinetic_cyp_induction_risk_table(examplinib_compounds,   examplinib_cyp_induction_data) #>  #>  #> Table: Risk for CYP induction by examplinib, basic kinetic model #>  #> |CYP     | $E_{max}$| $EC_{50}$ ($\\mu M$)|source    |$R$  |risk | #> |:-------|---------:|-------------------:|:---------|:----|:----| #> |CYP1A2  |      1.00|                  NA|study 007 |NA   |     | #> |CYP2B6  |      1.00|                  NA|study 007 |NA   |     | #> |CYP2C8  |        NA|                  NA|          |NA   |     | #> |CYP2C9  |        NA|                  NA|          |NA   |     | #> |CYP2C19 |        NA|                  NA|          |NA   |     | #> |CYP2D6  |        NA|                  NA|          |NA   |     | #> |CYP3A4  |      7.35|                1.64|study 007 |0.21 |Yes  | #>  #>  #> Table: Risk for CYP induction by M1, basic kinetic model #>  #> |CYP     | $E_{max}$| $EC_{50}$ ($\\mu M$)|source    |$R$  |risk | #> |:-------|---------:|-------------------:|:---------|:----|:----| #> |CYP1A2  |      1.00|                  NA|study 007 |NA   |     | #> |CYP2B6  |      6.98|                1.86|study 007 |0.55 |Yes  | #> |CYP2C8  |        NA|                  NA|          |NA   |     | #> |CYP2C9  |        NA|                  NA|          |NA   |     | #> |CYP2C19 |        NA|                  NA|          |NA   |     | #> |CYP2D6  |        NA|                  NA|          |NA   |     | #> |CYP3A4  |     22.70|                1.10|study 007 |0.19 |Yes  | kinetic_cyp_induction_risk_table(examplinib_compounds,   examplinib_cyp_induction_data, show_dose = TRUE) #>  #>  #> Table: Risk for CYP induction by examplinib (450 mg), basic kinetic model #>  #> |CYP     | $E_{max}$| $EC_{50}$ ($\\mu M$)|source    |$R$  |risk | #> |:-------|---------:|-------------------:|:---------|:----|:----| #> |CYP1A2  |      1.00|                  NA|study 007 |NA   |     | #> |CYP2B6  |      1.00|                  NA|study 007 |NA   |     | #> |CYP2C8  |        NA|                  NA|          |NA   |     | #> |CYP2C9  |        NA|                  NA|          |NA   |     | #> |CYP2C19 |        NA|                  NA|          |NA   |     | #> |CYP2D6  |        NA|                  NA|          |NA   |     | #> |CYP3A4  |      7.35|                1.64|study 007 |0.21 |Yes  | #>  #>  #> Table: Risk for CYP induction by M1, basic kinetic model #>  #> |CYP     | $E_{max}$| $EC_{50}$ ($\\mu M$)|source    |$R$  |risk | #> |:-------|---------:|-------------------:|:---------|:----|:----| #> |CYP1A2  |      1.00|                  NA|study 007 |NA   |     | #> |CYP2B6  |      6.98|                1.86|study 007 |0.55 |Yes  | #> |CYP2C8  |        NA|                  NA|          |NA   |     | #> |CYP2C9  |        NA|                  NA|          |NA   |     | #> |CYP2C19 |        NA|                  NA|          |NA   |     | #> |CYP2D6  |        NA|                  NA|          |NA   |     | #> |CYP3A4  |     22.70|                1.10|study 007 |0.19 |Yes  |"},{"path":"/reference/make_perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Make a perpetrator object from compound data — make_perpetrator","title":"Make a perpetrator object from compound data — make_perpetrator","text":"function creates perpetrator object key compound data. Note 'source' field empty. want include source information, can either use new_perpetrator() takes input data may include source information, can create perpetrator object text input string using read_perpetrators().","code":""},{"path":"/reference/make_perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Make a perpetrator object from compound data — make_perpetrator","text":"","code":"make_perpetrator(   name,   dose,   imaxss,   mw,   type = \"parent\",   oral = TRUE,   fu = 1,   fumic = 1,   rb = 1,   fa = 1,   fg = 1,   ka = 0.1,   solubility = Inf )"},{"path":"/reference/make_perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Make a perpetrator object from compound data — make_perpetrator","text":"name compound name character. dose clinical dose mg. imaxss (total) steady-state Cmax ng/ml. mw molar weight g/mol. type compound type character. Must either 'parent' metabolite'. oral Oral administration Boolean. Defaults TRUE. fu fraction unbound numeric. Defaults 1. fumic fraction unbound microsomes. Defaults 1. rb blood--plasma concentration ratio. Defaults 1. fa fraction absorbed. Defaults 1. fg fraction escaping gut metabolism. Defaults 1. ka absorption rate constant /ml. Defaults 0.1 /ml. solubility aqueus solubility mg/l. Defaults Inf,","code":""},{"path":"/reference/make_perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Make a perpetrator object from compound data — make_perpetrator","text":"perpetrator object.","code":""},{"path":[]},{"path":"/reference/make_perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Make a perpetrator object from compound data — make_perpetrator","text":"","code":"make_perpetrator(\"test\", 100, 1000, 500) #> ----- DDI perpetrator object ----- #> name         test              #> oral         TRUE              #> mw           500               #> dose         100               #> imaxss       1000              #> fu           1                 #> fumic        1                 #> rb           1                 #> fa           1                 #> fg           1                 #> ka           0.1               #> solubility   Inf"},{"path":"/reference/mech_stat_cyp_risk.html","id":null,"dir":"Reference","previous_headings":"","what":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"CYP perpetration risk per mechanistic-static modeling","code":""},{"path":"/reference/mech_stat_cyp_risk.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"","code":"mech_stat_cyp_risk(   perp,   cyp_inh,   cyp_ind,   cyp_tdi = NULL,   d = 1,   include_induction = TRUE,   substr = cyp_reference_substrates,   cyp_kdeg = cyp_turnover )"},{"path":"/reference/mech_stat_cyp_risk.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"perp perpetrator object. cyp_inh CYP inhibition data data frame. following fields expected: 'name' name perpetrator compound. 'cyp' CYP enzyme (upper case) character. 'ki' \\(K_i\\) \\(\\mu M\\) numeric. 'source' Optional source information character. cyp_ind CYP induction data data frame. following fields expected: 'name' name perpetrator compound character. 'cyp' CYP enzyme (upper case) character. 'emax' \\(E_{max}\\), .e., maximum induction effect determined vitro numeric. 'ec50' \\(EC_{50}\\) \\(\\mu M\\) numeric. 'maxc' maximal concentration \\(\\mu M\\) tested vitro assay numeric. 'source' Optional source information character. cyp_tdi CYP TDI data data frame. following fields expected: 'name' perpetrator compound name character. 'cyp' CYP enzyme character. 'ki' \\(K_I\\) \\(\\mu M\\) numeric. 'kinact' \\(k_{inact}\\) 1/h numeric. 'source' Optional source information character, d Scaling factor, defaults 1. include_induction Switch define whether induction effects included calculation (C-terms per FDA guideline) substr CYP probe substrates used data frame, defaults cyp_reference_substrates. data frame expected following fields: 'cyp' CYP enzyme (upper case) character. 'substrate' substrate name character. 'fgut' fraction drug escaping gut metabolism. 'fm' fraction drug undergoes hepatic metabolism. 'fmcyp' fraction metabolized respective CYP enzyme. cyp_kdeg CYP turnover data data frame. Defaults built-reference data, cyp_turnover.","code":""},{"path":"/reference/mech_stat_cyp_risk.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"data frame.","code":""},{"path":"/reference/mech_stat_cyp_risk.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"approach, AUC ratios CYP-specific probe substrates calculated based known intestinal hepatic metabolism. Direct (competitive) time-dependent inhibition terms, well enzyme induction terms considered. details, refer section 7.5.1.2 ICH M12 guideline. $$AUCR = \\frac{1}{A_g*B_g*C_g* \\left(1-F_g \\right)+F_g} * \\frac{1}{A_h*B_h*C_h*f_m+\\left(1-f_m\\right)}$$ individual terms :","code":""},{"path":"/reference/mech_stat_cyp_risk.html","id":"reversible-inhibition","dir":"Reference","previous_headings":"","what":"Reversible inhibition","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"$$A_g = \\frac{1}{1+\\frac{I_g}{K_i}}$$ $$A_h = \\frac{1}{1+\\frac{I_h}{K_i}}$$","code":""},{"path":"/reference/mech_stat_cyp_risk.html","id":"time-dependent-inhibition","dir":"Reference","previous_headings":"","what":"Time-dependent inhibition","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"$$B_g = \\frac{k_{deg,g}}{k_{deg,g} + \\frac{I_g*k_{inact}}{I_g+K_I}}$$ $$B_h = \\frac{k_{deg,h}}{k_{deg,h} + \\frac{I_h*k_{inact}}{I_h+K_I}}$$","code":""},{"path":"/reference/mech_stat_cyp_risk.html","id":"induction","dir":"Reference","previous_headings":"","what":"Induction","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"$$C_g = 1 + \\frac{d*E_{max}*I_g}{I_g+EC_{50}}$$ $$C_h = 1 + \\frac{d*E_{max}*I_h}{I_h+EC_{50}}$$ hepatic inlet concentration \\(I_h=I_{max,inlet,u}\\) intestinal concentration \\(I_g=I_{enteric,u}\\), see key_concentrations(). \\(d\\) scaling factor CYP induction term standard value 1. different value can used warranted prior experience experimental setup.","code":""},{"path":[]},{"path":"/reference/mech_stat_cyp_risk.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"","code":"mech_stat_cyp_risk(examplinib_parent, examplinib_cyp_inhibition_data,   examplinib_cyp_induction_data) #>       cyp   substrate   kiu fgut   fm fmcyp         Ag        Ah Bg Bh       Cg #> 1  CYP1A2  tizanidine    NA 1.00 0.95  0.98 1.00000000 1.0000000  1  1 1.000000 #> 2  CYP2B6        <NA>    NA   NA   NA    NA 1.00000000 1.0000000  1  1 1.000000 #> 3  CYP2C8 repaglinide 11.00 1.00 1.00  0.61 0.62551298 0.9827625  1  1 1.000000 #> 4  CYP2C9  S-warfarin  0.60 1.00 1.00  0.91 0.08350072 0.7566792  1  1 1.000000 #> 5 CYP2C19  omeprazole  0.25 1.00 1.00  0.87 0.03657341 0.5644126  1  1 1.000000 #> 6  CYP2D6 desipramine    NA 1.00 1.00  0.85 1.00000000 1.0000000  1  1 1.000000 #> 7  CYP3A4   midazolam 12.50 0.57 0.96  1.00 0.65494520 0.9847995  1  1 6.884569 #>         Ch      aucr  risk #> 1 1.000000 1.0000000 FALSE #> 2 1.000000        NA    NA #> 3 1.000000 1.0106266 FALSE #> 4 1.000000 1.2843927  TRUE #> 5 1.000000 1.6102050  TRUE #> 6 1.000000 1.0000000 FALSE #> 7 1.773674 0.2321612  TRUE mech_stat_cyp_risk(examplinib_parent, examplinib_cyp_inhibition_data,   examplinib_cyp_induction_data, examplinib_cyp_tdi_data) #>       cyp   substrate   kiu fgut   fm fmcyp         Ag        Ah        Bg #> 1  CYP1A2  tizanidine    NA 1.00 0.95  0.98 1.00000000 1.0000000 1.0000000 #> 2  CYP2B6        <NA>    NA   NA   NA    NA 1.00000000 1.0000000 1.0000000 #> 3  CYP2C8 repaglinide 11.00 1.00 1.00  0.61 0.62551298 0.9827625 1.0000000 #> 4  CYP2C9  S-warfarin  0.60 1.00 1.00  0.91 0.08350072 0.7566792 1.0000000 #> 5 CYP2C19  omeprazole  0.25 1.00 1.00  0.87 0.03657341 0.5644126 1.0000000 #> 6  CYP2D6 desipramine    NA 1.00 1.00  0.85 1.00000000 1.0000000 1.0000000 #> 7  CYP3A4   midazolam 12.50 0.57 0.96  1.00 0.65494520 0.9847995 0.4348241 #>          Bh       Cg       Ch      aucr  risk #> 1 1.0000000 1.000000 1.000000 1.0000000 FALSE #> 2 1.0000000 1.000000 1.000000        NA    NA #> 3 1.0000000 1.000000 1.000000 1.0106266 FALSE #> 4 1.0000000 1.000000 1.000000 1.2843927  TRUE #> 5 1.0000000 1.000000 1.000000 1.6102050  TRUE #> 6 1.0000000 1.000000 1.000000 1.0000000 FALSE #> 7 0.4757909 6.884569 1.773674 0.8446594 FALSE mech_stat_cyp_risk(examplinib_parent, examplinib_cyp_inhibition_data,   examplinib_cyp_induction_data, examplinib_cyp_tdi_data,   include_induction = FALSE) #>       cyp   substrate   kiu fgut   fm fmcyp         Ag        Ah        Bg #> 1  CYP1A2  tizanidine    NA 1.00 0.95  0.98 1.00000000 1.0000000 1.0000000 #> 2  CYP2B6        <NA>    NA   NA   NA    NA 1.00000000 1.0000000 1.0000000 #> 3  CYP2C8 repaglinide 11.00 1.00 1.00  0.61 0.62551298 0.9827625 1.0000000 #> 4  CYP2C9  S-warfarin  0.60 1.00 1.00  0.91 0.08350072 0.7566792 1.0000000 #> 5 CYP2C19  omeprazole  0.25 1.00 1.00  0.87 0.03657341 0.5644126 1.0000000 #> 6  CYP2D6 desipramine    NA 1.00 1.00  0.85 1.00000000 1.0000000 1.0000000 #> 7  CYP3A4   midazolam 12.50 0.57 0.96  1.00 0.65494520 0.9847995 0.4348241 #>          Bh Cg Ch     aucr  risk #> 1 1.0000000  1  1 1.000000 FALSE #> 2 1.0000000  1  1       NA    NA #> 3 1.0000000  1  1 1.010627 FALSE #> 4 1.0000000  1  1 1.284393  TRUE #> 5 1.0000000  1  1 1.610205  TRUE #> 6 1.0000000  1  1 1.000000 FALSE #> 7 0.4757909  1  1 2.948311  TRUE mech_stat_cyp_risk(examplinib_parent, examplinib_cyp_inhibition_data, NULL) #>       cyp   substrate   kiu fgut   fm fmcyp         Ag        Ah Bg Bh Cg Ch #> 1  CYP1A2  tizanidine    NA 1.00 0.95  0.98 1.00000000 1.0000000  1  1  1  1 #> 2  CYP2B6        <NA>    NA   NA   NA    NA 1.00000000 1.0000000  1  1  1  1 #> 3  CYP2C8 repaglinide 11.00 1.00 1.00  0.61 0.62551298 0.9827625  1  1  1  1 #> 4  CYP2C9  S-warfarin  0.60 1.00 1.00  0.91 0.08350072 0.7566792  1  1  1  1 #> 5 CYP2C19  omeprazole  0.25 1.00 1.00  0.87 0.03657341 0.5644126  1  1  1  1 #> 6  CYP2D6 desipramine    NA 1.00 1.00  0.85 1.00000000 1.0000000  1  1  1  1 #> 7  CYP3A4   midazolam 12.50 0.57 0.96  1.00 0.65494520 0.9847995  1  1  1  1 #>       aucr  risk #> 1 1.000000 FALSE #> 2       NA    NA #> 3 1.010627 FALSE #> 4 1.284393  TRUE #> 5 1.610205  TRUE #> 6 1.000000 FALSE #> 7 1.191612 FALSE"},{"path":"/reference/mech_stat_cyp_risk_summary.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary statement for mechanistic-static modeling of CYP modulation — mech_stat_cyp_risk_summary","title":"Summary statement for mechanistic-static modeling of CYP modulation — mech_stat_cyp_risk_summary","text":"Summary statement mechanistic-static modeling CYP modulation","code":""},{"path":"/reference/mech_stat_cyp_risk_summary.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary statement for mechanistic-static modeling of CYP modulation — mech_stat_cyp_risk_summary","text":"","code":"mech_stat_cyp_risk_summary(   perp,   cyp_inh,   cyp_ind,   cyp_tdi = NULL,   d = 1,   include_induction = TRUE,   substr = cyp_reference_substrates,   cyp_kdeg = cyp_turnover )"},{"path":"/reference/mech_stat_cyp_risk_summary.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary statement for mechanistic-static modeling of CYP modulation — mech_stat_cyp_risk_summary","text":"perp perpetrator object. cyp_inh CYP inhibition data data frame. following fields expected: 'name' name perpetrator compound. 'cyp' CYP enzyme (upper case) character. 'ki' \\(K_i\\) \\(\\mu M\\) numeric. 'source' Optional source information character. cyp_ind CYP induction data data frame. following fields expected: 'name' name perpetrator compound character. 'cyp' CYP enzyme (upper case) character. 'emax' \\(E_{max}\\), .e., maximum induction effect determined vitro numeric. 'ec50' \\(EC_{50}\\) \\(\\mu M\\) numeric. 'maxc' maximal concentration \\(\\mu M\\) tested vitro assay numeric. 'source' Optional source information character. cyp_tdi CYP TDI data data frame. following fields expected: 'name' perpetrator compound name character. 'cyp' CYP enzyme character. 'ki' \\(K_I\\) \\(\\mu M\\) numeric. 'kinact' \\(k_{inact}\\) 1/h numeric. 'source' Optional source information character, d Scaling factor, defaults 1. include_induction Switch define whether induction effects included calculation (C-terms per FDA guideline) substr CYP probe substrates used data frame, defaults cyp_reference_substrates. data frame expected following fields: 'cyp' CYP enzyme (upper case) character. 'substrate' substrate name character. 'fgut' fraction drug escaping gut metabolism. 'fm' fraction drug undergoes hepatic metabolism. 'fmcyp' fraction metabolized respective CYP enzyme. cyp_kdeg CYP turnover data data frame. Defaults built-reference data, cyp_turnover.","code":""},{"path":"/reference/mech_stat_cyp_risk_summary.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary statement for mechanistic-static modeling of CYP modulation — mech_stat_cyp_risk_summary","text":"Markdown-formatted text output.","code":""},{"path":"/reference/mech_stat_cyp_risk_summary.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Summary statement for mechanistic-static modeling of CYP modulation — mech_stat_cyp_risk_summary","text":"","code":"mech_stat_cyp_risk_summary(examplinib_parent,   examplinib_cyp_inhibition_data, examplinib_cyp_induction_data) #> [1] \"* based on mechanistic-static modeling (S-warfarin and omeprazole), examplinib has a clinical risk for inhibition of CYP2C9 and CYP2C19\" #> [2] \"* based on mechanistic-static modeling (midazolam), examplinib has a clinical risk for induction of CYP3A4\"                              mech_stat_cyp_risk_summary(examplinib_metabolite,   examplinib_cyp_inhibition_data, examplinib_cyp_induction_data) #> NULL mech_stat_cyp_risk_summary(examplinib_compounds,   examplinib_cyp_inhibition_data, examplinib_cyp_induction_data) #> [1] \"* based on mechanistic-static modeling (S-warfarin and omeprazole), examplinib has a clinical risk for inhibition of CYP2C9 and CYP2C19\" #> [2] \"* based on mechanistic-static modeling (midazolam), examplinib has a clinical risk for induction of CYP3A4\""},{"path":"/reference/mech_stat_cyp_risk_summary.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary statement for mechanistic-static modeling of CYP modulation — mech_stat_cyp_risk_summary.list","title":"Summary statement for mechanistic-static modeling of CYP modulation — mech_stat_cyp_risk_summary.list","text":"Summary statement mechanistic-static modeling CYP modulation","code":""},{"path":"/reference/mech_stat_cyp_risk_summary.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary statement for mechanistic-static modeling of CYP modulation — mech_stat_cyp_risk_summary.list","text":"","code":"# S3 method for class 'list' mech_stat_cyp_risk_summary(perp, ...)"},{"path":"/reference/mech_stat_cyp_risk_summary.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary statement for mechanistic-static modeling of CYP modulation — mech_stat_cyp_risk_summary.list","text":"perp perpetrator object. ... parameters.","code":""},{"path":"/reference/mech_stat_cyp_risk_summary.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary statement for mechanistic-static modeling of CYP modulation — mech_stat_cyp_risk_summary.list","text":"Markdown-formatted text output.","code":""},{"path":"/reference/mech_stat_cyp_risk_summary.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary statement for mechanistic-static modeling of CYP modulation — mech_stat_cyp_risk_summary.perpetrator","title":"Summary statement for mechanistic-static modeling of CYP modulation — mech_stat_cyp_risk_summary.perpetrator","text":"Summary statement mechanistic-static modeling CYP modulation","code":""},{"path":"/reference/mech_stat_cyp_risk_summary.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary statement for mechanistic-static modeling of CYP modulation — mech_stat_cyp_risk_summary.perpetrator","text":"","code":"# S3 method for class 'perpetrator' mech_stat_cyp_risk_summary(   perp,   cyp_inh,   cyp_ind = NULL,   cyp_tdi = NULL,   d = 1,   include_induction = TRUE,   substr = cyp_reference_substrates,   cyp_kdeg = cyp_turnover )"},{"path":"/reference/mech_stat_cyp_risk_summary.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary statement for mechanistic-static modeling of CYP modulation — mech_stat_cyp_risk_summary.perpetrator","text":"perp perpetrator object. cyp_inh CYP inhibition data data frame. following fields expected: 'name' name perpetrator compound. 'cyp' CYP enzyme (upper case) character. 'ki' \\(K_i\\) \\(\\mu M\\) numeric. 'source' Optional source information character. cyp_ind CYP induction data data frame. following fields expected: 'name' name perpetrator compound character. 'cyp' CYP enzyme (upper case) character. 'emax' \\(E_{max}\\), .e., maximum induction effect determined vitro numeric. 'ec50' \\(EC_{50}\\) \\(\\mu M\\) numeric. 'maxc' maximal concentration \\(\\mu M\\) tested vitro assay numeric. 'source' Optional source information character. cyp_tdi CYP TDI data data frame. following fields expected: 'name' perpetrator compound name character. 'cyp' CYP enzyme character. 'ki' \\(K_I\\) \\(\\mu M\\) numeric. 'kinact' \\(k_{inact}\\) 1/h numeric. 'source' Optional source information character, d Scaling factor, defaults 1. include_induction Switch define whether induction effects included calculation (C-terms per FDA guideline) substr CYP probe substrates used data frame, defaults cyp_reference_substrates. data frame expected following fields: 'cyp' CYP enzyme (upper case) character. 'substrate' substrate name character. 'fgut' fraction drug escaping gut metabolism. 'fm' fraction drug undergoes hepatic metabolism. 'fmcyp' fraction metabolized respective CYP enzyme. cyp_kdeg CYP turnover data data frame. Defaults built-reference data, cyp_turnover.","code":""},{"path":"/reference/mech_stat_cyp_risk_summary.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary statement for mechanistic-static modeling of CYP modulation — mech_stat_cyp_risk_summary.perpetrator","text":"Markdown-formatted text output.","code":""},{"path":"/reference/mech_stat_cyp_risk_table.html","id":null,"dir":"Reference","previous_headings":"","what":"CYP perpetration risk table as per mechanistic-static modeling — mech_stat_cyp_risk_table","title":"CYP perpetration risk table as per mechanistic-static modeling — mech_stat_cyp_risk_table","text":"CYP perpetration risk table per mechanistic-static modeling","code":""},{"path":"/reference/mech_stat_cyp_risk_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"CYP perpetration risk table as per mechanistic-static modeling — mech_stat_cyp_risk_table","text":"","code":"mech_stat_cyp_risk_table(   perp,   cyp_inh,   cyp_ind,   cyp_tdi = NULL,   include_induction = TRUE,   substr = cyp_reference_substrates,   cyp_kdeg = cyp_turnover,   na.rm = FALSE,   show_dose = FALSE )"},{"path":"/reference/mech_stat_cyp_risk_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"CYP perpetration risk table as per mechanistic-static modeling — mech_stat_cyp_risk_table","text":"perp perpetrator object. cyp_inh CYP inhibition data data frame. following fields expected: 'name' name perpetrator compound. 'cyp' CYP enzyme (upper case) character. 'ki' \\(K_i\\) \\(\\mu M\\) numeric. 'source' Optional source information character. cyp_ind CYP induction data data frame. following fields expected: 'name' name perpetrator compound character. 'cyp' CYP enzyme (upper case) character. 'emax' \\(E_{max}\\), .e., maximum induction effect determined vitro numeric. 'ec50' \\(EC_{50}\\) \\(\\mu M\\) numeric. 'maxc' maximal concentration \\(\\mu M\\) tested vitro assay numeric. 'source' Optional source information character. cyp_tdi CYP TDI data data frame. following fields expected: 'name' perpetrator compound name character. 'cyp' CYP enzyme character. 'ki' \\(K_I\\) \\(\\mu M\\) numeric. 'kinact' \\(k_{inact}\\) 1/h numeric. 'source' Optional source information character, include_induction Switch define whether induction effects included calculation (C-terms per FDA guideline) substr CYP probe substrates used data frame, defaults cyp_reference_substrates. data frame expected following fields: 'cyp' CYP enzyme (upper case) character. 'substrate' substrate name character. 'fgut' fraction drug escaping gut metabolism. 'fm' fraction drug undergoes hepatic metabolism. 'fmcyp' fraction metabolized respective CYP enzyme. cyp_kdeg CYP turnover data data frame. Defaults built-reference data, cyp_turnover. na.rm Switch define whether rows lacking \\(K_I\\) \\(k_{deg}\\) data removed output. show_dose Show perpetrator dose table title, defaults FALSE.","code":""},{"path":"/reference/mech_stat_cyp_risk_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"CYP perpetration risk table as per mechanistic-static modeling — mech_stat_cyp_risk_table","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/mech_stat_cyp_risk_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"CYP perpetration risk table as per mechanistic-static modeling — mech_stat_cyp_risk_table","text":"","code":"mech_stat_cyp_risk_table(   examplinib_parent,   examplinib_cyp_inhibition_data,   examplinib_cyp_induction_data) #>  #>  #> Table: Mechanistic static modeling of the CYP inhibition risk for examplinib #>  #> |CYP     |substrate   | $F_{gut}$| $f_m$| $f_{m,CYP}$| $A_g$| $A_h$| $B_g$| $B_h$| $C_g$| $C_h$|AUCR  |risk | #> |:-------|:-----------|---------:|-----:|-----------:|-----:|-----:|-----:|-----:|-----:|-----:|:-----|:----| #> |CYP1A2  |tizanidine  |      1.00|  0.95|        0.98|  1.00|  1.00|     1|     1|  1.00|  1.00|1.000 |No   | #> |CYP2B6  |NA          |        NA|    NA|          NA|  1.00|  1.00|     1|     1|  1.00|  1.00|NA    |     | #> |CYP2C8  |repaglinide |      1.00|  1.00|        0.61|  0.63|  0.98|     1|     1|  1.00|  1.00|1.011 |No   | #> |CYP2C9  |S-warfarin  |      1.00|  1.00|        0.91|  0.08|  0.76|     1|     1|  1.00|  1.00|1.284 |Yes  | #> |CYP2C19 |omeprazole  |      1.00|  1.00|        0.87|  0.04|  0.56|     1|     1|  1.00|  1.00|1.610 |Yes  | #> |CYP2D6  |desipramine |      1.00|  1.00|        0.85|  1.00|  1.00|     1|     1|  1.00|  1.00|1.000 |No   | #> |CYP3A4  |midazolam   |      0.57|  0.96|        1.00|  0.65|  0.98|     1|     1|  6.88|  1.77|0.232 |Yes  | mech_stat_cyp_risk_table(   examplinib_compounds,   examplinib_cyp_inhibition_data,   examplinib_cyp_induction_data,   examplinib_cyp_tdi_data) #>  #>  #> Table: Mechanistic static modeling of the CYP inhibition risk for examplinib #>  #> |CYP     |substrate   | $F_{gut}$| $f_m$| $f_{m,CYP}$| $A_g$| $A_h$| $B_g$| $B_h$| $C_g$| $C_h$|AUCR  |risk | #> |:-------|:-----------|---------:|-----:|-----------:|-----:|-----:|-----:|-----:|-----:|-----:|:-----|:----| #> |CYP1A2  |tizanidine  |      1.00|  0.95|        0.98|  1.00|  1.00|  1.00|  1.00|  1.00|  1.00|1.000 |No   | #> |CYP2B6  |NA          |        NA|    NA|          NA|  1.00|  1.00|  1.00|  1.00|  1.00|  1.00|NA    |     | #> |CYP2C8  |repaglinide |      1.00|  1.00|        0.61|  0.63|  0.98|  1.00|  1.00|  1.00|  1.00|1.011 |No   | #> |CYP2C9  |S-warfarin  |      1.00|  1.00|        0.91|  0.08|  0.76|  1.00|  1.00|  1.00|  1.00|1.284 |Yes  | #> |CYP2C19 |omeprazole  |      1.00|  1.00|        0.87|  0.04|  0.56|  1.00|  1.00|  1.00|  1.00|1.610 |Yes  | #> |CYP2D6  |desipramine |      1.00|  1.00|        0.85|  1.00|  1.00|  1.00|  1.00|  1.00|  1.00|1.000 |No   | #> |CYP3A4  |midazolam   |      0.57|  0.96|        1.00|  0.65|  0.98|  0.43|  0.48|  6.88|  1.77|0.845 |No   | #>  #>  #> Table: Mechanistic static modeling of the CYP inhibition risk for M1 #>  #> |CYP    |substrate  | $F_{gut}$| $f_m$| $f_{m,CYP}$| $A_g$| $A_h$| $B_g$| $B_h$| $C_g$| $C_h$|AUCR |risk | #> |:------|:----------|---------:|-----:|-----------:|-----:|-----:|-----:|-----:|-----:|-----:|:----|:----| #> |CYP2C9 |S-warfarin |         1|     1|        0.91|  0.99|  0.99|     1|     1|     1|     1|1.01 |No   | mech_stat_cyp_risk_table(   examplinib_compounds,   examplinib_cyp_inhibition_data,   examplinib_cyp_induction_data,   examplinib_cyp_tdi_data, show_dose = TRUE) #>  #>  #> Table: Mechanistic static modeling of the CYP inhibition risk for examplinib (450 mg) #>  #> |CYP     |substrate   | $F_{gut}$| $f_m$| $f_{m,CYP}$| $A_g$| $A_h$| $B_g$| $B_h$| $C_g$| $C_h$|AUCR  |risk | #> |:-------|:-----------|---------:|-----:|-----------:|-----:|-----:|-----:|-----:|-----:|-----:|:-----|:----| #> |CYP1A2  |tizanidine  |      1.00|  0.95|        0.98|  1.00|  1.00|  1.00|  1.00|  1.00|  1.00|1.000 |No   | #> |CYP2B6  |NA          |        NA|    NA|          NA|  1.00|  1.00|  1.00|  1.00|  1.00|  1.00|NA    |     | #> |CYP2C8  |repaglinide |      1.00|  1.00|        0.61|  0.63|  0.98|  1.00|  1.00|  1.00|  1.00|1.011 |No   | #> |CYP2C9  |S-warfarin  |      1.00|  1.00|        0.91|  0.08|  0.76|  1.00|  1.00|  1.00|  1.00|1.284 |Yes  | #> |CYP2C19 |omeprazole  |      1.00|  1.00|        0.87|  0.04|  0.56|  1.00|  1.00|  1.00|  1.00|1.610 |Yes  | #> |CYP2D6  |desipramine |      1.00|  1.00|        0.85|  1.00|  1.00|  1.00|  1.00|  1.00|  1.00|1.000 |No   | #> |CYP3A4  |midazolam   |      0.57|  0.96|        1.00|  0.65|  0.98|  0.43|  0.48|  6.88|  1.77|0.845 |No   | #>  #>  #> Table: Mechanistic static modeling of the CYP inhibition risk for M1 #>  #> |CYP    |substrate  | $F_{gut}$| $f_m$| $f_{m,CYP}$| $A_g$| $A_h$| $B_g$| $B_h$| $C_g$| $C_h$|AUCR |risk | #> |:------|:----------|---------:|-----:|-----------:|-----:|-----:|-----:|-----:|-----:|-----:|:----|:----| #> |CYP2C9 |S-warfarin |         1|     1|        0.91|  0.99|  0.99|     1|     1|     1|     1|1.01 |No   |"},{"path":"/reference/name.html","id":null,"dir":"Reference","previous_headings":"","what":"Generic name method — name","title":"Generic name method — name","text":"Generic name method","code":""},{"path":"/reference/name.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Generic name method — name","text":"","code":"name(obj)"},{"path":"/reference/name.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Generic name method — name","text":"obj perpetrator object.","code":""},{"path":"/reference/name.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Generic name method — name","text":"name perpetrator character.","code":""},{"path":"/reference/name.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Name of a perpetrator compound — name.perpetrator","title":"Name of a perpetrator compound — name.perpetrator","text":"Name perpetrator compound","code":""},{"path":"/reference/name.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Name of a perpetrator compound — name.perpetrator","text":"","code":"# S3 method for class 'perpetrator' name(obj)"},{"path":"/reference/name.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Name of a perpetrator compound — name.perpetrator","text":"obj perpetrator object.","code":""},{"path":"/reference/name.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Name of a perpetrator compound — name.perpetrator","text":"name perpetrator character.","code":""},{"path":"/reference/name.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Name of a perpetrator compound — name.perpetrator","text":"","code":"name(examplinib_parent) #> [1] \"examplinib\""},{"path":[]},{"path":"/reference/names_string.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Perpetrator names as comma-separated string — names_string","text":"","code":"names_string(perps)"},{"path":"/reference/names_string.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Perpetrator names as comma-separated string — names_string","text":"perps perpetrator objects list.","code":""},{"path":"/reference/names_string.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Perpetrator names as comma-separated string — names_string","text":"output string.","code":""},{"path":"/reference/new_perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Perpetrator object constructor — new_perpetrator","title":"Perpetrator object constructor — new_perpetrator","text":"Convert data frame perpetrator object.","code":""},{"path":"/reference/new_perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Perpetrator object constructor — new_perpetrator","text":"","code":"new_perpetrator(df)"},{"path":"/reference/new_perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Perpetrator object constructor — new_perpetrator","text":"df data frame converted perpetrator object. See 'Details' expected format fields.","code":""},{"path":"/reference/new_perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Perpetrator object constructor — new_perpetrator","text":"perpetrator object.","code":""},{"path":"/reference/new_perpetrator.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Perpetrator object constructor — new_perpetrator","text":"input data frame columns 'param', 'value' source'. Rows following parameters ('param') expected input: following example valid input data frame:","code":"param      value        source 1        name examplinib 2        oral       TRUE 3          mw      492.6 4        dose        450 clinical dose 5      imaxss       3530     study 001 6          fu      0.023     study 002 7       fumic          1       default 8          rb          1     study 003 9          fa       0.81     study 003 10         fg          1       default 11         ka    0.00267       unknown 12 solubility        Inf       default"},{"path":[]},{"path":"/reference/nice_enumeration.html","id":null,"dir":"Reference","previous_headings":"","what":"Nice enumeration of multiple strings — nice_enumeration","title":"Nice enumeration of multiple strings — nice_enumeration","text":"Nice enumeration multiple strings","code":""},{"path":"/reference/nice_enumeration.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Nice enumeration of multiple strings — nice_enumeration","text":"","code":"nice_enumeration(items, conjunction = \"and\")"},{"path":"/reference/nice_enumeration.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Nice enumeration of multiple strings — nice_enumeration","text":"items Items enumerate character. conjunction conjunction last penultmate items.","code":""},{"path":"/reference/nice_enumeration.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Nice enumeration of multiple strings — nice_enumeration","text":"Enumeration character.","code":""},{"path":"/reference/nice_enumeration.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Nice enumeration of multiple strings — nice_enumeration","text":"","code":"nice_enumeration(\"A\") #> [1] \"A\" nice_enumeration(c(\"A\", \"B\")) #> [1] \"A and B\" nice_enumeration(c(\"A\", \"B\", \"C\")) #> [1] \"A, B and C\" nice_enumeration(c(\"A\", \"B\", \"C\"), conjunction = \"or\") #> [1] \"A, B or C\""},{"path":"/reference/property_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of perpetrator drug properties — property_table","title":"Table of perpetrator drug properties — property_table","text":"function generates markdown-formatted table key properties perpetrator object.","code":""},{"path":"/reference/property_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of perpetrator drug properties — property_table","text":"","code":"property_table(obj)"},{"path":"/reference/property_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of perpetrator drug properties — property_table","text":"obj perpetrator object list perpetrator objects.","code":""},{"path":"/reference/property_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of perpetrator drug properties — property_table","text":"markdown-formatted table.","code":""},{"path":"/reference/property_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of perpetrator drug properties — property_table","text":"","code":"property_table(examplinib_parent) #>  #>  #> Table: Compound parameters for examplinib #>  #> |parameter            |value   |source        | #> |:--------------------|:-------|:-------------| #> |oral                 |TRUE    |              | #> |$MW$ (g/mol)         |492.6   |              | #> |$dose$ (mg)          |450     |clinical dose | #> |$C_{max,ss}$ (ng/ml) |3530    |study 001     | #> |$f_u$                |0.023   |study 002     | #> |$f_{u,mic}$          |1       |default       | #> |$R_B$                |1       |study 003     | #> |$F_a$                |0.81    |study 003     | #> |$F_g$                |1       |default       | #> |$k_a$ (1/min)        |0.00267 |unknown       | #> |$solubility$ (mg/l)  |Inf     |default       | property_table(examplinib_compounds) #>  #>  #> Table: Compound parameters for examplinib #>  #> |parameter            |value   |source        | #> |:--------------------|:-------|:-------------| #> |oral                 |TRUE    |              | #> |$MW$ (g/mol)         |492.6   |              | #> |$dose$ (mg)          |450     |clinical dose | #> |$C_{max,ss}$ (ng/ml) |3530    |study 001     | #> |$f_u$                |0.023   |study 002     | #> |$f_{u,mic}$          |1       |default       | #> |$R_B$                |1       |study 003     | #> |$F_a$                |0.81    |study 003     | #> |$F_g$                |1       |default       | #> |$k_a$ (1/min)        |0.00267 |unknown       | #> |$solubility$ (mg/l)  |Inf     |default       | #>  #>  #> Table: Compound parameters for M1 #>  #> |parameter            |value  |source    | #> |:--------------------|:------|:---------| #> |oral                 |FALSE  |          | #> |$MW$ (g/mol)         |506.56 |          | #> |$dose$ (mg)          |NA     |          | #> |$C_{max,ss}$ (ng/ml) |1038   |study 001 | #> |$f_u$                |0.012  |study 002 | #> |$f_{u,mic}$          |1      |default   | #> |$R_B$                |1      |study 002 | #> |$solubility$ (mg/l)  |Inf    |default   |"},{"path":"/reference/read_cyp_inhibitor_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Read CYP inhibition data — read_cyp_inhibitor_data","title":"Read CYP inhibition data — read_cyp_inhibitor_data","text":"Read CYP inhibition data file text connection.","code":""},{"path":"/reference/read_cyp_inhibitor_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Read CYP inhibition data — read_cyp_inhibitor_data","text":"","code":"read_cyp_inhibitor_data(source)"},{"path":"/reference/read_cyp_inhibitor_data.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Read CYP inhibition data — read_cyp_inhibitor_data","text":"source file text connection read .","code":""},{"path":"/reference/read_cyp_inhibitor_data.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Read CYP inhibition data — read_cyp_inhibitor_data","text":"data frame.","code":""},{"path":"/reference/read_cyp_inhibitor_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Read CYP inhibition data — read_cyp_inhibitor_data","text":"following, comma-separated fields expected input (order): 'name' perpetrator compound name character. 'cyp' CYP enzyme (upper case) character. 'ki' \\(k_i\\) µM numeric. 'source' Optional source information character. Lines starting '#' considered comments evaluated. following example valid input:","code":"# PARENT     # compound, CYP, ki, source     examplinib, CYP1A2,  NA     examplinib, CYP2B6,  NA,     examplinib, CYP2C8,  11,   study 001     examplinib, CYP2C9,  0.6, study 001     examplinib, CYP2C19, 0.25,   study 001     examplinib, CYP2D6,  NA,     examplinib, CYP3A4,  12.5, study 001      # METABOLITE     M1,         CYP2C9,  4.4,  study 002"},{"path":"/reference/read_cyp_inhibitor_data.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Read CYP inhibition data — read_cyp_inhibitor_data","text":"","code":"read_cyp_inhibitor_data(textConnection(examplinib_cyp_inhibition_string)) #>         name     cyp   ki    source #> 1 examplinib  CYP1A2   NA           #> 2 examplinib  CYP2B6   NA           #> 3 examplinib  CYP2C8   11 study 001 #> 4 examplinib  CYP2C9  0.6 study 001 #> 5 examplinib CYP2C19 0.25 study 001 #> 6 examplinib  CYP2D6   NA           #> 7 examplinib  CYP3A4 12.5 study 001 #> 8         M1  CYP2C9  4.4 study 002"},{"path":"/reference/read_inducer_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Read csv-formatted CYP inducer data — read_inducer_data","title":"Read csv-formatted CYP inducer data — read_inducer_data","text":"function loads CYP inducer data csv file. following fields expected: 'name' name perpetrator compound character. 'cyp' CYP enzyme (upper case) character. 'emax' \\(E_{max}\\), .e., maximum induction effect determined vitro numeric. 'ec50' \\(EC_{50}\\) µM numeric. 'maxc' maximal concentration µM tested vitro assay numeric. 'source' Optional source information character.","code":""},{"path":"/reference/read_inducer_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Read csv-formatted CYP inducer data — read_inducer_data","text":"","code":"read_inducer_data(source)"},{"path":"/reference/read_inducer_data.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Read csv-formatted CYP inducer data — read_inducer_data","text":"source connection read .","code":""},{"path":"/reference/read_inducer_data.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Read csv-formatted CYP inducer data — read_inducer_data","text":"data data frame.","code":""},{"path":"/reference/read_inducer_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Read csv-formatted CYP inducer data — read_inducer_data","text":"Comment lines must start '#'. valid source , e.g.,","code":"examplinib, CYP1A2,  1,    NA,   5,  study 007 examplinib, CYP2B6,  1,    NA,   5,  study 007 examplinib, CYP2C8,  NA,   NA,   NA, examplinib, CYP2C9,  NA,   NA,   NA, examplinib, CYP2C19, NA,   NA,   NA, examplinib, CYP2D6,  NA,   NA,   NA, examplinib, CYP3A4,   7.35, 1.64, 3,  study 007   M1, CYP1A2,  1,    NA,   5,  study 007 M1, CYP2B6,  6.98, 1.86, 5,  study 007 M1, CYP2C8,  NA,   NA,   NA, M1, CYP2C9,  NA,   NA,   NA, M1, CYP2C19, NA,   NA,   NA, M1, CYP2D6,  NA,   NA,   NA, M1, CYP3A4,  22.7, 1.1,  5,  study 007"},{"path":"/reference/read_inducer_data.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Read csv-formatted CYP inducer data — read_inducer_data","text":"","code":"read_inducer_data(textConnection(examplinib_cyp_induction_string)) #>          name     cyp  emax ec50 maxc    source #> 1  examplinib  CYP1A2  1.00   NA    5 study 007 #> 2  examplinib  CYP2B6  1.00   NA    5 study 007 #> 3  examplinib  CYP2C8    NA   NA   NA           #> 4  examplinib  CYP2C9    NA   NA   NA           #> 5  examplinib CYP2C19    NA   NA   NA           #> 6  examplinib  CYP2D6    NA   NA   NA           #> 7  examplinib  CYP3A4  7.35 1.64    3 study 007 #> 8          M1  CYP1A2  1.00   NA    5 study 007 #> 9          M1  CYP2B6  6.98 1.86    5 study 007 #> 10         M1  CYP2C8    NA   NA   NA           #> 11         M1  CYP2C9    NA   NA   NA           #> 12         M1 CYP2C19    NA   NA   NA           #> 13         M1  CYP2D6    NA   NA   NA           #> 14         M1  CYP3A4 22.70 1.10    5 study 007"},{"path":"/reference/read_inhibitor_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Read csv-formatted CYP inhibition data — read_inhibitor_data","title":"Read csv-formatted CYP inhibition data — read_inhibitor_data","text":"function deprecated favor read_cyp_inhibitor_data(), read_ugt_inhibitor_data() read_transporter_inhibitor_data().","code":""},{"path":"/reference/read_inhibitor_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Read csv-formatted CYP inhibition data — read_inhibitor_data","text":"","code":"read_inhibitor_data(source)"},{"path":"/reference/read_inhibitor_data.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Read csv-formatted CYP inhibition data — read_inhibitor_data","text":"source connection read .","code":""},{"path":"/reference/read_inhibitor_data.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Read csv-formatted CYP inhibition data — read_inhibitor_data","text":"data frame.","code":""},{"path":"/reference/read_inhibitor_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Read csv-formatted CYP inhibition data — read_inhibitor_data","text":"function loads CYP inhibition data csv file. expected fields (order) compound name, CYP enzyme, Ki source information respective data. latter field may remain empty. Comment lines must start '#'. valid source , e.g.,","code":"# PARENT     # compound, CYP, ki, source     examplinib, CYP1A2,  NA     examplinib, CYP2B6,  NA,     examplinib, CYP2C8,  11,   study 001     examplinib, CYP2C9,  0.6, study 001     examplinib, CYP2C19, 0.25,   study 001     examplinib, CYP2D6,  NA,     examplinib, CYP3A4,  12.5, study 001      # METABOLITE     M1,         CYP2C9,  4.4,  study 002"},{"path":"/reference/read_perpetrators.html","id":null,"dir":"Reference","previous_headings":"","what":"Read perpetrator information from file or text string — read_perpetrators","title":"Read perpetrator information from file or text string — read_perpetrators","text":"input source can either file name string text connection. can used read compound data string.","code":""},{"path":"/reference/read_perpetrators.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Read perpetrator information from file or text string — read_perpetrators","text":"","code":"read_perpetrators(source)"},{"path":"/reference/read_perpetrators.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Read perpetrator information from file or text string — read_perpetrators","text":"source file name text connection read .","code":""},{"path":"/reference/read_perpetrators.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Read perpetrator information from file or text string — read_perpetrators","text":"perpetrator object one compound input source, list perpetrator objects.","code":""},{"path":"/reference/read_perpetrators.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Read perpetrator information from file or text string — read_perpetrators","text":"following fields expected input (order): 'name' compound name character. 'parameter' parameter character. 'value' respective value character. 'source' Optional source information character. following parameters expected: 'oral' Boolean (.e., TRUE FALSE) indicate whether drug subject first-pass effects. 'mw' molar weight g/mol numeric. 'dose' clinically administered dose mg numeric. 'imaxss' (total) \\(C_{max}\\) ng/ml administration clinical dose. 'fu' free unbound) fraction drug plasma. 'fumic' free (unbound) fraction microsomal preparations. 'rb' blood--plasma concentration ratio. 'fa' fraction absorbed drug. 'fg' fraction administered dose escaping gut metabolism. 'ka' absorption rate constant 1/min. 'solubility' aqueous solubility compound mg/l. Lines starting '#' considered comments evaluated. Note multiple compounds, e.g., parent metabolites may included perpetrator file. example valid compound file:","code":"# PARENT     # compound,  param,    value,     source     examplinib,  oral,     TRUE,     examplinib,  mw,       492.6,     examplinib,  dose,     450,       clinical dose     examplinib,  imaxss,   3530,      study 001     examplinib,  fu,       0.023,     study 002     examplinib,  fumic,    1,         default     examplinib,  rb,       1,         study 003     examplinib,  fa,       0.81,      study 003     examplinib,  fg,       1,         default     examplinib,  ka,       0.00267,   unknown      # METABOLITE     # compound,  param,    value,     source     M1,          oral,     FALSE,     M1,          mw,       506.56,     M1,          dose,     NA,     M1,          imaxss,   1038,      study 001     M1,          fu,       0.012,     study 002     M1,          fumic,    1,         default     M1,          rb,       1,         study 002     M1,          fa,       NA,     M1,          fg,       NA,     M1,          ka,       NA,"},{"path":"/reference/read_perpetrators.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Read perpetrator information from file or text string — read_perpetrators","text":"","code":"read_perpetrators(textConnection(examplinib_compounds_string)) #> $M1 #> ----- DDI perpetrator object ----- #> name         M1                    #> oral         FALSE                 #> mw           506.56                #> dose         NA                    #> imaxss       1038     study 001    #> fu           0.012    study 002    #> fumic        1        default      #> rb           1        study 002    #> fa           NA                    #> fg           NA                    #> ka           NA                    #> solubility   Inf      default #> $examplinib #> ----- DDI perpetrator object ----- #> name         examplinib                    #> oral         TRUE                          #> mw           492.6                         #> dose         450          clinical dose    #> imaxss       3530         study 001        #> fu           0.023        study 002        #> fumic        1            default          #> rb           1            study 003        #> fa           0.81         study 003        #> fg           1            default          #> ka           0.00267      unknown          #> solubility   Inf          default"},{"path":"/reference/read_tdi_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Read csv-formatted CYP TDI data — read_tdi_data","title":"Read csv-formatted CYP TDI data — read_tdi_data","text":"function reads comma-separated CYP TDI data file text connection.","code":""},{"path":"/reference/read_tdi_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Read csv-formatted CYP TDI data — read_tdi_data","text":"","code":"read_tdi_data(source)"},{"path":"/reference/read_tdi_data.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Read csv-formatted CYP TDI data — read_tdi_data","text":"source connection read .","code":""},{"path":"/reference/read_tdi_data.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Read csv-formatted CYP TDI data — read_tdi_data","text":"data frame.","code":""},{"path":"/reference/read_tdi_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Read csv-formatted CYP TDI data — read_tdi_data","text":"following fields expected (order): 'name' perpetrator compound name character. 'cyp' CYP enzyme (upper case) character. 'ki' \\(K_I\\) µM numeric. 'kinact' \\(k_{inact}\\) \\(1/h\\) numeric. 'source' Optional source information character. Lines starting '#' interpreted comments evaluated. valid data set , e.g.,","code":"# compound, CYP, Ki, Kinact, source       examplinib, CYP3A4, 0.17,   0.04, study 001"},{"path":"/reference/read_transporter_inhibitor_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Read transporter inhibition data — read_transporter_inhibitor_data","title":"Read transporter inhibition data — read_transporter_inhibitor_data","text":"Read transporter inhibition data file text connection.","code":""},{"path":"/reference/read_transporter_inhibitor_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Read transporter inhibition data — read_transporter_inhibitor_data","text":"","code":"read_transporter_inhibitor_data(source)"},{"path":"/reference/read_transporter_inhibitor_data.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Read transporter inhibition data — read_transporter_inhibitor_data","text":"source file text connection read .","code":""},{"path":"/reference/read_transporter_inhibitor_data.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Read transporter inhibition data — read_transporter_inhibitor_data","text":"data frame.","code":""},{"path":"/reference/read_transporter_inhibitor_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Read transporter inhibition data — read_transporter_inhibitor_data","text":"following, comma-separated fields expected (order): 'name' perpetrator compound name character. 'cyp' UGT enzyme (upper case) character. 'ic50' \\(IC_{50}\\) inhibition μM. 'source' Optional source information character. Lines starting '#' considered comments evaluated. following example valid input:","code":"# name,     parameter, value, source examplinib, Pgp,       0.41,  study 005 examplinib, BCRP,      1.9,  study 005 examplinib, OCT1,      2.3,    study 006 examplinib, OATP1B1,   177,   study 006 examplinib, OATP1B3,   35,   study 006 examplinib, OAT1,      271, examplinib, OAT3,      300, examplinib, BSEP,      12.8, examplinib, OCT2,      67,    study 006 examplinib, MATE1,     3.6,    study 006 examplinib, MATE2k,    1.1,    study 006"},{"path":"/reference/read_transporter_inhibitor_data.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Read transporter inhibition data — read_transporter_inhibitor_data","text":"","code":"read_transporter_inhibitor_data(textConnection(examplinib_transporter_inhibition_string)) #>          name transporter ic50    source #> 1  examplinib         Pgp 0.41 study 005 #> 2  examplinib        BCRP  1.9 study 005 #> 3  examplinib        OCT1  2.3 study 006 #> 4  examplinib     OATP1B1  177 study 006 #> 5  examplinib     OATP1B3   35 study 006 #> 6  examplinib        OAT1  271           #> 7  examplinib        OAT3  300           #> 8  examplinib        BSEP 12.8           #> 9  examplinib        OCT2   67 study 006 #> 10 examplinib       MATE1  3.6 study 006 #> 11 examplinib      MATE2k  1.1 study 006"},{"path":"/reference/read_ugt_inhibitor_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Read UGT inhibition data — read_ugt_inhibitor_data","title":"Read UGT inhibition data — read_ugt_inhibitor_data","text":"Read UGT inhibition data file text connection.","code":""},{"path":"/reference/read_ugt_inhibitor_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Read UGT inhibition data — read_ugt_inhibitor_data","text":"","code":"read_ugt_inhibitor_data(source)"},{"path":"/reference/read_ugt_inhibitor_data.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Read UGT inhibition data — read_ugt_inhibitor_data","text":"source file text connection read .","code":""},{"path":"/reference/read_ugt_inhibitor_data.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Read UGT inhibition data — read_ugt_inhibitor_data","text":"data frame.","code":""},{"path":"/reference/read_ugt_inhibitor_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Read UGT inhibition data — read_ugt_inhibitor_data","text":"following, comma-separated fields expected input: 'name' perpetrator compound name character. 'ugt' UGT enzyme (upper case) character. 'ic50' \\(IC_{50}\\) µM numeric. 'source' Optional source information character. Lines starting '#' considered comments evaluated. following example valid input:","code":"# enzyme, IC50, source # parent compound  examplinib, UGT1A1, 15, study 009 examplinib, UGT1A3, 15, study 009 examplinib, UGT1A4, 15, study 009 examplinib, UGT1A6, 15, study 009 examplinib, UGT1A9, 3.8, study 009 examplinib, UGT2B7, 15, study 009 examplinib, UGT2B15, 15, study 009 examplinib, UGT2B17, 6.1, study 009  # metabolite M1  M1, UGT1A1, 1.1, study 009 M1, UGT1A3, 5.8, study 009 M1, UGT1A4, 6.2, study 009 M1, UGT1A6, 15, study 009 M1, UGT1A9, 3.6, study 009 M1, UGT2B7, 15, study 009 M1, UGT2B15, 9.6, study 009 M1, UGT2B17, 2.2, study 009"},{"path":"/reference/read_ugt_inhibitor_data.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Read UGT inhibition data — read_ugt_inhibitor_data","text":"","code":"read_ugt_inhibitor_data(textConnection(examplinib_ugt_inhibition_string)) #>          name     ugt ic50    source #> 1  examplinib  UGT1A1   15 study 009 #> 2  examplinib  UGT1A3   15 study 009 #> 3  examplinib  UGT1A4   15 study 009 #> 4  examplinib  UGT1A6   15 study 009 #> 5  examplinib  UGT1A9  3.8 study 009 #> 6  examplinib  UGT2B7   15 study 009 #> 7  examplinib UGT2B15   15 study 009 #> 8  examplinib UGT2B17  6.1 study 009 #> 9          M1  UGT1A1  1.1 study 009 #> 10         M1  UGT1A3  5.8 study 009 #> 11         M1  UGT1A4  6.2 study 009 #> 12         M1  UGT1A6   15 study 009 #> 13         M1  UGT1A9  3.6 study 009 #> 14         M1  UGT2B7   15 study 009 #> 15         M1 UGT2B15  9.6 study 009 #> 16         M1 UGT2B17  2.2 study 009"},{"path":"/reference/static_cyp_induction_risk.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic static CYP induction risk — static_cyp_induction_risk","title":"Basic static CYP induction risk — static_cyp_induction_risk","text":"Basic static CYP induction risk","code":""},{"path":"/reference/static_cyp_induction_risk.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic static CYP induction risk — static_cyp_induction_risk","text":"","code":"static_cyp_induction_risk(perp, cyp_ind)"},{"path":"/reference/static_cyp_induction_risk.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic static CYP induction risk — static_cyp_induction_risk","text":"perp perpetrator object list thereof. cyp_ind CYP induction data data frame. following fields expected: 'name' name perpetrator compound character. 'cyp' CYP enzyme (upper case) character. 'emax' \\(E_{max}\\), .e., maximum induction effect determined vitro numeric. 'ec50' \\(EC_{50}\\) \\(\\mu M\\) numeric. 'maxc' maximal concentration \\(\\mu M\\) tested vitro assay numeric. 'source' Optional source information character.","code":""},{"path":"/reference/static_cyp_induction_risk.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic static CYP induction risk — static_cyp_induction_risk","text":"data frame.","code":""},{"path":"/reference/static_cyp_induction_risk.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Basic static CYP induction risk — static_cyp_induction_risk","text":"basic fold-change method evaluates whether maximal fold-change mRNA expression CYP enzyme, relative vehicle control, > 2-fold concentrations 50-fold unbound Cmax,ss - provided concentration-dependent increases mRNA observed vitro. vitro experiments concentrations 50-fold unbound Cmax,ss tested, noted output. Also note ICH guideline specifies positive control used vitro studies result least 6-fold mRNA increases, otherwise induction risk ruled mRNA increase CYP enzyme > 20% positive control. , well condition concentration-dependent increase mRNA increase (see ), must confirmed manually user. details, refer section 2.1.4.1 ICH M1s2 guideline","code":""},{"path":"/reference/static_cyp_induction_risk.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic static CYP induction risk — static_cyp_induction_risk","text":"","code":"static_cyp_induction_risk(examplinib_parent, examplinib_cyp_induction_data) #>       cyp emax maxc    source maxc_imaxssu  risk     note #> 1  CYP1A2 1.00    5 study 007         30.3 FALSE Low maxc #> 2  CYP2B6 1.00    5 study 007         30.3 FALSE Low maxc #> 3  CYP2C8   NA   NA                     NA    NA          #> 4  CYP2C9   NA   NA                     NA    NA          #> 5 CYP2C19   NA   NA                     NA    NA          #> 6  CYP2D6   NA   NA                     NA    NA          #> 7  CYP3A4 7.35    3 study 007         18.2  TRUE Low maxc"},{"path":"/reference/static_cyp_induction_risk_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table","text":"Table basic static CYP induction risk","code":""},{"path":"/reference/static_cyp_induction_risk_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table","text":"","code":"static_cyp_induction_risk_table(perp, cyp_ind, na.rm = F, show_dose = FALSE)"},{"path":"/reference/static_cyp_induction_risk_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table","text":"perp perpetrator object list thereof. cyp_ind CYP induction data data frame. following fields expected: 'name' name perpetrator compound character. 'cyp' CYP enzyme (upper case) character. 'emax' \\(E_{max}\\), .e., maximum induction effect determined vitro numeric. 'ec50' \\(EC_{50}\\) \\(\\mu M\\) numeric. 'maxc' maximal concentration \\(\\mu M\\) tested vitro assay numeric. 'source' Optional source information character. na.rm Switch define whether rows lacking \\(E_{max}\\) data removed output. Defaults FALSE. show_dose Show perpetrator dose table title, defaults FALSE.","code":""},{"path":"/reference/static_cyp_induction_risk_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/static_cyp_induction_risk_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table","text":"","code":"static_cyp_induction_risk_table(examplinib_parent,   examplinib_cyp_induction_data) #>  #>  #> Table: Risk for hepatic CYP induction by examplinib, basic mRNA fold-change method #>  #> |CYP     | $E_{max}$| $max c$ ($\\mu M$)|source    | $max c/C_{max,ss,u}$|risk |notes    | #> |:-------|---------:|-----------------:|:---------|--------------------:|:----|:--------| #> |CYP1A2  |      1.00|                 5|study 007 |                 30.3|No   |Low maxc | #> |CYP2B6  |      1.00|                 5|study 007 |                 30.3|No   |Low maxc | #> |CYP2C8  |        NA|                NA|          |                   NA|     |         | #> |CYP2C9  |        NA|                NA|          |                   NA|     |         | #> |CYP2C19 |        NA|                NA|          |                   NA|     |         | #> |CYP2D6  |        NA|                NA|          |                   NA|     |         | #> |CYP3A4  |      7.35|                 3|study 007 |                 18.2|Yes  |Low maxc | static_cyp_induction_risk_table(examplinib_compounds,   examplinib_cyp_induction_data) #>  #>  #> Table: Risk for hepatic CYP induction by examplinib, basic mRNA fold-change method #>  #> |CYP     | $E_{max}$| $max c$ ($\\mu M$)|source    | $max c/C_{max,ss,u}$|risk |notes    | #> |:-------|---------:|-----------------:|:---------|--------------------:|:----|:--------| #> |CYP1A2  |      1.00|                 5|study 007 |                 30.3|No   |Low maxc | #> |CYP2B6  |      1.00|                 5|study 007 |                 30.3|No   |Low maxc | #> |CYP2C8  |        NA|                NA|          |                   NA|     |         | #> |CYP2C9  |        NA|                NA|          |                   NA|     |         | #> |CYP2C19 |        NA|                NA|          |                   NA|     |         | #> |CYP2D6  |        NA|                NA|          |                   NA|     |         | #> |CYP3A4  |      7.35|                 3|study 007 |                 18.2|Yes  |Low maxc | #>  #>  #> Table: Risk for hepatic CYP induction by M1, basic mRNA fold-change method #>  #> |CYP     | $E_{max}$| $max c$ ($\\mu M$)|source    | $max c/C_{max,ss,u}$|risk |notes | #> |:-------|---------:|-----------------:|:---------|--------------------:|:----|:-----| #> |CYP1A2  |      1.00|                 5|study 007 |                203.3|No   |      | #> |CYP2B6  |      6.98|                 5|study 007 |                203.3|Yes  |      | #> |CYP2C8  |        NA|                NA|          |                   NA|     |      | #> |CYP2C9  |        NA|                NA|          |                   NA|     |      | #> |CYP2C19 |        NA|                NA|          |                   NA|     |      | #> |CYP2D6  |        NA|                NA|          |                   NA|     |      | #> |CYP3A4  |     22.70|                 5|study 007 |                203.3|Yes  |      | static_cyp_induction_risk_table(examplinib_compounds,   examplinib_cyp_induction_data, show_dose = TRUE) #>  #>  #> Table: Risk for hepatic CYP induction by examplinib (450 mg), basic mRNA fold-change method #>  #> |CYP     | $E_{max}$| $max c$ ($\\mu M$)|source    | $max c/C_{max,ss,u}$|risk |notes    | #> |:-------|---------:|-----------------:|:---------|--------------------:|:----|:--------| #> |CYP1A2  |      1.00|                 5|study 007 |                 30.3|No   |Low maxc | #> |CYP2B6  |      1.00|                 5|study 007 |                 30.3|No   |Low maxc | #> |CYP2C8  |        NA|                NA|          |                   NA|     |         | #> |CYP2C9  |        NA|                NA|          |                   NA|     |         | #> |CYP2C19 |        NA|                NA|          |                   NA|     |         | #> |CYP2D6  |        NA|                NA|          |                   NA|     |         | #> |CYP3A4  |      7.35|                 3|study 007 |                 18.2|Yes  |Low maxc | #>  #>  #> Table: Risk for hepatic CYP induction by M1, basic mRNA fold-change method #>  #> |CYP     | $E_{max}$| $max c$ ($\\mu M$)|source    | $max c/C_{max,ss,u}$|risk |notes | #> |:-------|---------:|-----------------:|:---------|--------------------:|:----|:-----| #> |CYP1A2  |      1.00|                 5|study 007 |                203.3|No   |      | #> |CYP2B6  |      6.98|                 5|study 007 |                203.3|Yes  |      | #> |CYP2C8  |        NA|                NA|          |                   NA|     |      | #> |CYP2C9  |        NA|                NA|          |                   NA|     |      | #> |CYP2C19 |        NA|                NA|          |                   NA|     |      | #> |CYP2D6  |        NA|                NA|          |                   NA|     |      | #> |CYP3A4  |     22.70|                 5|study 007 |                203.3|Yes  |      |"},{"path":"/reference/transporter_inhibition_risk.html","id":null,"dir":"Reference","previous_headings":"","what":"Drug transporter inhibition risk — transporter_inhibition_risk","title":"Drug transporter inhibition risk — transporter_inhibition_risk","text":"Drug transporter inhibition risk","code":""},{"path":"/reference/transporter_inhibition_risk.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Drug transporter inhibition risk — transporter_inhibition_risk","text":"","code":"transporter_inhibition_risk(   perp,   transporter_inh,   transporter_ref = transporter_reference_data )"},{"path":"/reference/transporter_inhibition_risk.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Drug transporter inhibition risk — transporter_inhibition_risk","text":"perp perpetrator object. transporter_inh Transporter inhibition data data frame. following fields expected: 'name' perpetrator compound name. 'cyp' UGT enzyme (upper case) character. 'ic50' \\(IC_{50}\\) inhibition μM. 'source' Optional source information character. transporter_ref Transporter reference data, see transporter_reference_data details.","code":""},{"path":"/reference/transporter_inhibition_risk.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Drug transporter inhibition risk — transporter_inhibition_risk","text":"data frame.","code":""},{"path":"/reference/transporter_inhibition_risk.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Drug transporter inhibition risk — transporter_inhibition_risk","text":"metric assessment transporter interactions \\(R=[]/IC_{50}\\). relevant perpetrator concentrations \\([]\\) regulatory thresholds concern :","code":""},{"path":[]},{"path":"/reference/transporter_inhibition_risk.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Drug transporter inhibition risk — transporter_inhibition_risk","text":"","code":"transporter_inhibition_risk(examplinib_parent,   examplinib_transporter_inhibition_data) #>    transporter   ic50    source          i            r threshold  risk #> 1      Pgp_int   0.41 study 005       igut 8.912391e+03     10.00  TRUE #> 2      Pgp_sys   0.41 study 005    imaxssu 4.019984e-01      0.02  TRUE #> 3     BCRP_int   1.90 study 005       igut 1.923200e+03     10.00  TRUE #> 4     BCRP_sys   1.90 study 005    imaxssu 8.674701e-02      0.02  TRUE #> 5      OATP1B1 177.00 study 006 imaxinletu 1.090047e-03      0.10 FALSE #> 6      OATP1B3  35.00 study 006 imaxinletu 5.512525e-03      0.10 FALSE #> 7         OAT1 271.00              imaxssu 6.081894e-04      0.10 FALSE #> 8         OAT3 300.00              imaxssu 5.493978e-04      0.10 FALSE #> 9         BSEP  12.80              imaxssu 1.287651e-02      0.10 FALSE #> 10        OCT1   2.30 study 006       <NA>           NA        NA    NA #> 11        OCT2  67.00 study 006    imaxssu 2.459990e-03      0.10 FALSE #> 12       MATE1   3.60 study 006    imaxssu 4.578315e-02      0.02  TRUE #> 13      MATE2k   1.10 study 006    imaxssu 1.498358e-01      0.02  TRUE"},{"path":"/reference/transporter_inhibition_risk_summary.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary statement for transporter inhibition — transporter_inhibition_risk_summary","title":"Summary statement for transporter inhibition — transporter_inhibition_risk_summary","text":"Summary statement transporter inhibition","code":""},{"path":"/reference/transporter_inhibition_risk_summary.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary statement for transporter inhibition — transporter_inhibition_risk_summary","text":"","code":"transporter_inhibition_risk_summary(   perp,   transporter_inh,   transporter_ref = transporter_reference_data )"},{"path":"/reference/transporter_inhibition_risk_summary.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary statement for transporter inhibition — transporter_inhibition_risk_summary","text":"perp perpetrator object. transporter_inh Transporter inhibition data data frame. following fields expected: 'name' perpetrator compound name. 'cyp' UGT enzyme (upper case) character. 'ic50' \\(IC_{50}\\) inhibition μM. 'source' Optional source information character. transporter_ref Transporter reference data, see transporter_reference_data details.","code":""},{"path":"/reference/transporter_inhibition_risk_summary.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary statement for transporter inhibition — transporter_inhibition_risk_summary","text":"Markdown-formatted text output.","code":""},{"path":"/reference/transporter_inhibition_risk_summary.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Summary statement for transporter inhibition — transporter_inhibition_risk_summary","text":"","code":"transporter_inhibition_risk_summary(examplinib_parent,   examplinib_transporter_inhibition_data) #> [1] \"* examplinib has a clinical risk for inhibition of P-gp (intestinal), P-gp (hepatic), BCRP (intestinal), BCRP (hepatic), MATE1 and MATE2k\" transporter_inhibition_risk_summary(examplinib_metabolite,   examplinib_transporter_inhibition_data) #> NULL transporter_inhibition_risk_summary(examplinib_compounds,   examplinib_transporter_inhibition_data) #> [1] \"* examplinib has a clinical risk for inhibition of P-gp (intestinal), P-gp (hepatic), BCRP (intestinal), BCRP (hepatic), MATE1 and MATE2k\""},{"path":"/reference/transporter_inhibition_risk_summary.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary statement for transporter inhibition for a list of compounds — transporter_inhibition_risk_summary.list","title":"Summary statement for transporter inhibition for a list of compounds — transporter_inhibition_risk_summary.list","text":"Summary statement transporter inhibition list compounds","code":""},{"path":"/reference/transporter_inhibition_risk_summary.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary statement for transporter inhibition for a list of compounds — transporter_inhibition_risk_summary.list","text":"","code":"# S3 method for class 'list' transporter_inhibition_risk_summary(perp, ...)"},{"path":"/reference/transporter_inhibition_risk_summary.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary statement for transporter inhibition for a list of compounds — transporter_inhibition_risk_summary.list","text":"perp perpetrator object. ... parameters.","code":""},{"path":"/reference/transporter_inhibition_risk_summary.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary statement for transporter inhibition for a list of compounds — transporter_inhibition_risk_summary.list","text":"Markdown-formatted text output.","code":""},{"path":"/reference/transporter_inhibition_risk_summary.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary statement for transporter inhibition for a precipitant compound — transporter_inhibition_risk_summary.perpetrator","title":"Summary statement for transporter inhibition for a precipitant compound — transporter_inhibition_risk_summary.perpetrator","text":"Summary statement transporter inhibition precipitant compound","code":""},{"path":"/reference/transporter_inhibition_risk_summary.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary statement for transporter inhibition for a precipitant compound — transporter_inhibition_risk_summary.perpetrator","text":"","code":"# S3 method for class 'perpetrator' transporter_inhibition_risk_summary(   perp,   transporter_inh,   transporter_ref = transporter_reference_data )"},{"path":"/reference/transporter_inhibition_risk_summary.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary statement for transporter inhibition for a precipitant compound — transporter_inhibition_risk_summary.perpetrator","text":"perp perpetrator object. transporter_inh Transporter inhibition data data frame. following fields expected: 'name' perpetrator compound name. 'cyp' UGT enzyme (upper case) character. 'ic50' \\(IC_{50}\\) inhibition μM. 'source' Optional source information character. transporter_ref Transporter reference data, see transporter_reference_data details.","code":""},{"path":"/reference/transporter_inhibition_risk_summary.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary statement for transporter inhibition for a precipitant compound — transporter_inhibition_risk_summary.perpetrator","text":"Markdown-formatted text output.","code":""},{"path":"/reference/transporter_inhibition_risk_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of drug transporter inhibition risks — transporter_inhibition_risk_table","title":"Table of drug transporter inhibition risks — transporter_inhibition_risk_table","text":"Table drug transporter inhibition risks","code":""},{"path":"/reference/transporter_inhibition_risk_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of drug transporter inhibition risks — transporter_inhibition_risk_table","text":"","code":"transporter_inhibition_risk_table(   perp,   transporter_inh,   transporter_ref = transporter_reference_data,   na.rm = F,   show_dose = FALSE )"},{"path":"/reference/transporter_inhibition_risk_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of drug transporter inhibition risks — transporter_inhibition_risk_table","text":"perp perpetrator object. transporter_inh Transporter inhibition data data frame. following fields expected: 'name' perpetrator compound name. 'cyp' UGT enzyme (upper case) character. 'ic50' \\(IC_{50}\\) inhibition μM. 'source' Optional source information character. transporter_ref Transporter reference data, see transporter_reference_data details. na.rm Exclude rows lacking \\(IC_{50}\\) data output, logical. show_dose Show_dose Show perpetrator dose table title, logical. Defaults FALSE.","code":""},{"path":"/reference/transporter_inhibition_risk_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of drug transporter inhibition risks — transporter_inhibition_risk_table","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/transporter_inhibition_risk_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of drug transporter inhibition risks — transporter_inhibition_risk_table","text":"","code":"transporter_inhibition_risk_table(examplinib_parent,   examplinib_transporter_inhibition_data) #>  #>  #> Table: Risk for drug transporter inhibition by examplinib #>  #> |transporter | $IC_{50}$|source    |     $R$| threshold|risk | #> |:-----------|---------:|:---------|-------:|---------:|:----| #> |Pgp_int     |      0.41|study 005 | 8912.39|     10.00|Yes  | #> |Pgp_sys     |      0.41|study 005 |    0.40|      0.02|Yes  | #> |BCRP_int    |      1.90|study 005 | 1923.20|     10.00|Yes  | #> |BCRP_sys    |      1.90|study 005 |    0.09|      0.02|Yes  | #> |OATP1B1     |    177.00|study 006 |    0.00|      0.10|No   | #> |OATP1B3     |     35.00|study 006 |    0.01|      0.10|No   | #> |OAT1        |    271.00|          |    0.00|      0.10|No   | #> |OAT3        |    300.00|          |    0.00|      0.10|No   | #> |BSEP        |     12.80|          |    0.01|      0.10|No   | #> |OCT1        |      2.30|study 006 |      NA|        NA|     | #> |OCT2        |     67.00|study 006 |    0.00|      0.10|No   | #> |MATE1       |      3.60|study 006 |    0.05|      0.02|Yes  | #> |MATE2k      |      1.10|study 006 |    0.15|      0.02|Yes  | transporter_inhibition_risk_table(examplinib_compounds,   examplinib_transporter_inhibition_data) #>  #>  #> Table: Risk for drug transporter inhibition by examplinib #>  #> |transporter | $IC_{50}$|source    |     $R$| threshold|risk | #> |:-----------|---------:|:---------|-------:|---------:|:----| #> |Pgp_int     |      0.41|study 005 | 8912.39|     10.00|Yes  | #> |Pgp_sys     |      0.41|study 005 |    0.40|      0.02|Yes  | #> |BCRP_int    |      1.90|study 005 | 1923.20|     10.00|Yes  | #> |BCRP_sys    |      1.90|study 005 |    0.09|      0.02|Yes  | #> |OATP1B1     |    177.00|study 006 |    0.00|      0.10|No   | #> |OATP1B3     |     35.00|study 006 |    0.01|      0.10|No   | #> |OAT1        |    271.00|          |    0.00|      0.10|No   | #> |OAT3        |    300.00|          |    0.00|      0.10|No   | #> |BSEP        |     12.80|          |    0.01|      0.10|No   | #> |OCT1        |      2.30|study 006 |      NA|        NA|     | #> |OCT2        |     67.00|study 006 |    0.00|      0.10|No   | #> |MATE1       |      3.60|study 006 |    0.05|      0.02|Yes  | #> |MATE2k      |      1.10|study 006 |    0.15|      0.02|Yes  | transporter_inhibition_risk_table(examplinib_compounds,   examplinib_transporter_inhibition_data, show_dose = TRUE) #>  #>  #> Table: Risk for drug transporter inhibition by examplinib (450 mg) #>  #> |transporter | $IC_{50}$|source    |     $R$| threshold|risk | #> |:-----------|---------:|:---------|-------:|---------:|:----| #> |Pgp_int     |      0.41|study 005 | 8912.39|     10.00|Yes  | #> |Pgp_sys     |      0.41|study 005 |    0.40|      0.02|Yes  | #> |BCRP_int    |      1.90|study 005 | 1923.20|     10.00|Yes  | #> |BCRP_sys    |      1.90|study 005 |    0.09|      0.02|Yes  | #> |OATP1B1     |    177.00|study 006 |    0.00|      0.10|No   | #> |OATP1B3     |     35.00|study 006 |    0.01|      0.10|No   | #> |OAT1        |    271.00|          |    0.00|      0.10|No   | #> |OAT3        |    300.00|          |    0.00|      0.10|No   | #> |BSEP        |     12.80|          |    0.01|      0.10|No   | #> |OCT1        |      2.30|study 006 |      NA|        NA|     | #> |OCT2        |     67.00|study 006 |    0.00|      0.10|No   | #> |MATE1       |      3.60|study 006 |    0.05|      0.02|Yes  | #> |MATE2k      |      1.10|study 006 |    0.15|      0.02|Yes  |"},{"path":"/reference/transporter_reference_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Drug transporter reference data — transporter_reference_data","title":"Drug transporter reference data — transporter_reference_data","text":"Drug transporter reference data","code":""},{"path":"/reference/transporter_reference_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Drug transporter reference data — transporter_reference_data","text":"","code":"transporter_reference_data"},{"path":"/reference/transporter_reference_data.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Drug transporter reference data — transporter_reference_data","text":"'transporter' name drug transporter protein. 'threshold' regulatory threshold clinically relevant interactions. '' precipitant concentration metric applicable interaction.","code":""},{"path":"/reference/transporter_reference_data.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Drug transporter reference data — transporter_reference_data","text":"Section 2 ICH M12 guideline.","code":""},{"path":"/reference/transporter_reference_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Drug transporter reference data — transporter_reference_data","text":"","code":"transporter , threshold , i Pgp_int     , 10        , igut Pgp_sys     , 0.02      , imaxssu BCRP_int    , 10        , igut BCRP_sys    , 0.02      , imaxssu OATP1B1     , 0.1       , imaxinletu OATP1B3     , 0.1       , imaxinletu OAT1        , 0.1       , imaxssu OAT3        , 0.1       , imaxssu BSEP        , 0.1       , imaxssu OCT2        , 0.1       , imaxssu MATE1       , 0.02      , imaxssu MATE2k      , 0.02      , imaxssu"},{"path":[]},{"path":"/reference/ugt_inhibition_risk_summary.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary statement for UGT inhibition — ugt_inhibition_risk_summary","title":"Summary statement for UGT inhibition — ugt_inhibition_risk_summary","text":"Summary statement UGT inhibition","code":""},{"path":"/reference/ugt_inhibition_risk_summary.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary statement for UGT inhibition — ugt_inhibition_risk_summary","text":"","code":"ugt_inhibition_risk_summary(perp, ugt_inh)"},{"path":"/reference/ugt_inhibition_risk_summary.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary statement for UGT inhibition — ugt_inhibition_risk_summary","text":"perp perpetrator object. ugt_inh UGT inhibition data data frame, following fields expected: 'name' name perpetrator compound. 'ugt' UGT enzyme (upper case) character. 'ic50' \\(IC_{50}\\) \\(\\mu M\\) numeric. 'source' Optional source information character.","code":""},{"path":"/reference/ugt_inhibition_risk_summary.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary statement for UGT inhibition — ugt_inhibition_risk_summary","text":"Markdown-formatted text output.","code":""},{"path":"/reference/ugt_inhibition_risk_summary.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Summary statement for UGT inhibition — ugt_inhibition_risk_summary","text":"","code":"ugt_inhibition_risk_summary(   examplinib_parent, examplinib_ugt_inhibition_data) #> [1] \"* examplinib has a clinical risk for inhibition of UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A9, UGT2B7, UGT2B15 and UGT2B17\" ugt_inhibition_risk_summary(   examplinib_compounds, examplinib_ugt_inhibition_data) #> [1] \"* examplinib has a clinical risk for inhibition of UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A9, UGT2B7, UGT2B15 and UGT2B17\" #> [2] \"* M1 has a clinical risk for inhibition of UGT1A1 and UGT2B17\""},{"path":"/reference/ugt_inhibition_risk_summary.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary statement for UGT inhibition for a list of compounds — ugt_inhibition_risk_summary.list","title":"Summary statement for UGT inhibition for a list of compounds — ugt_inhibition_risk_summary.list","text":"Summary statement UGT inhibition list compounds","code":""},{"path":"/reference/ugt_inhibition_risk_summary.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary statement for UGT inhibition for a list of compounds — ugt_inhibition_risk_summary.list","text":"","code":"# S3 method for class 'list' ugt_inhibition_risk_summary(perp, ...)"},{"path":"/reference/ugt_inhibition_risk_summary.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary statement for UGT inhibition for a list of compounds — ugt_inhibition_risk_summary.list","text":"perp perpetrator object. ... parameters.","code":""},{"path":"/reference/ugt_inhibition_risk_summary.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary statement for UGT inhibition for a list of compounds — ugt_inhibition_risk_summary.list","text":"Markdown-formatted text output.","code":""},{"path":"/reference/ugt_inhibition_risk_summary.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary statement for UGT inhibition for a precipitant compound — ugt_inhibition_risk_summary.perpetrator","title":"Summary statement for UGT inhibition for a precipitant compound — ugt_inhibition_risk_summary.perpetrator","text":"Summary statement UGT inhibition precipitant compound","code":""},{"path":"/reference/ugt_inhibition_risk_summary.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary statement for UGT inhibition for a precipitant compound — ugt_inhibition_risk_summary.perpetrator","text":"","code":"# S3 method for class 'perpetrator' ugt_inhibition_risk_summary(perp, ugt_inh)"},{"path":"/reference/ugt_inhibition_risk_summary.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary statement for UGT inhibition for a precipitant compound — ugt_inhibition_risk_summary.perpetrator","text":"perp perpetrator object. ugt_inh UGT inhibition data data frame, following fields expected: 'name' name perpetrator compound. 'ugt' UGT enzyme (upper case) character. 'ic50' \\(IC_{50}\\) \\(\\mu M\\) numeric. 'source' Optional source information character.","code":""},{"path":"/reference/ugt_inhibition_risk_summary.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary statement for UGT inhibition for a precipitant compound — ugt_inhibition_risk_summary.perpetrator","text":"Markdown-formatted text output.","code":""}]
